Rak płuca
Leczenie
Rak płuca pozostaje główną przyczyną zgonów nowotworowych, z około 156 900 zgonami rocznie w USA. Pięcioletnie przeżycie wynosi jedynie 15,6%, co wynika z późnej diagnozy w zaawansowanym stadium. Wczesne wykrycie, zwłaszcza dzięki badaniom przesiewowym, znacząco poprawia rokowanie – 20-letnia przeżywalność u pacjentów zdiagnozowanych w badaniach przesiewowych wynosi 81%, a w stadium I nawet 95%. Jedyną rekomendowaną metodą przesiewową jest coroczna niskodawkowa tomografia komputerowa (LDCT), która zmniejsza śmiertelność o około 20% u osób z grupy wysokiego ryzyka (wiek 50-80 lat, 20 paczkolat historii palenia, palenie w ciągu ostatnich 15 lat). Badania przesiewowe nie są zalecane u pacjentów z ciężką niewydolnością oddechową lub innymi poważnymi schorzeniami ograniczającymi leczenie chirurgiczne.
- Badanie przesiewowe w kierunku raka płuca
- Co to jest badanie przesiewowe w kierunku raka płuca?
- Metoda badania przesiewowego
- Kto powinien przejść badanie przesiewowe?
- Leczenie raka płuca wykrytego w badaniu przesiewowym
- Opcje leczenia dla wczesnych stadiów raka płuca
- Opcje leczenia dla zaawansowanego raka płuca
- Resekcja chirurgiczna
- Radioterapia
- Chemioterapia i terapie systemowe
- Leczenie specyficznych typów raka płuca
- Korzyści i ryzyko związane z badaniami przesiewowymi
- Integracja badań przesiewowych w kompleksową opiekę nad pacjentem
- Proces badania przesiewowego
- Multidyscyplinarne podejście do opieki
- Znaczenie zwiększania udziału w badaniach przesiewowych
- Przyszłość badań przesiewowych w kierunku raka płuca
Badanie przesiewowe w kierunku raka płuca
Rak płuca jest wiodącą przyczyną zgonów związanych z chorobami nowotworowymi zarówno w Stanach Zjednoczonych, jak i na całym świecie. Szacuje się, że każdego roku w USA z powodu raka płuca umiera około 156 900 osób (85 600 mężczyzn i 71 300 kobiet). Pięcioletnie wskaźniki przeżycia w przypadku raka płuca wynoszą tylko około 15,6%, częściowo dlatego, że u większości pacjentów w momencie początkowej diagnozy nowotwór jest już w zaawansowanym stadium.1 Wykrycie raka płuca we wczesnym stadium, gdy jest jeszcze możliwy do wyleczenia, znacząco poprawia wskaźniki przeżycia. Pacjenci, u których rak płuca zostaje zdiagnozowany poprzez badania przesiewowe, mają 20-letnią przeżywalność na poziomie 81%, a jeśli rak zostanie wykryty w najwcześniejszym stadium I i zastosuje się odpowiednią terapię, długoterminowa przeżywalność wynosi 95%.2
Co to jest badanie przesiewowe w kierunku raka płuca?
Badanie przesiewowe w kierunku raka płuca to proces wykorzystywany do wykrycia obecności raka płuca u osób, które poza tym są zdrowe, ale mają wysokie ryzyko zachorowania. Jest zalecane dla starszych osób, które przez długi czas paliły papierosy i które nie mają żadnych objawów raka płuca.3 Badania przesiewowe mogą wykryć nowotwór przed wystąpieniem objawów, co zwiększa szanse na skuteczne leczenie.4
Celem badań przesiewowych w kierunku raka płuca jest wykrycie choroby we wczesnym stadium, kiedy istnieje większa szansa na wyleczenie. W momencie rozwinięcia objawów raka płuca, nowotwór jest zwykle zbyt zaawansowany, aby możliwe było leczenie prowadzące do wyleczenia. Badania wykazują, że badania przesiewowe w kierunku raka płuca zmniejszają ryzyko śmierci z powodu tej choroby.5
Metoda badania przesiewowego
Jedynym zalecanym testem przesiewowym w kierunku raka płuca jest niskodawkowa tomografia komputerowa (LDCT). Lekarze używają skanów LDCT do badania płuc pod kątem raka płuca.6 Badanie to wykorzystuje promieniowanie rentgenowskie o niskiej dawce do wykonania szczegółowych obrazów płuc. Dzięki LDCT można wykryć nawet najmniejsze guzki na płucach, stosując o 90% mniej promieniowania niż tradycyjne badanie obrazowe klatki piersiowej.7
Badania wykazały, że coroczne badania przesiewowe z użyciem LDCT u osób z grupy wysokiego ryzyka mogą obniżyć ryzyko śmierci z powodu raka płuca o 20% w porównaniu do badań przesiewowych z użyciem konwencjonalnych zdjęć rentgenowskich klatki piersiowej.8 Drugi z badanych protokołów wykazał, że wśród mężczyzn z grupy wysokiego ryzyka, obecnych i byłych palaczy, którzy zostali losowo przydzieleni do czterech rund badań przesiewowych LDCT, odnotowano 24% redukcję śmiertelności z powodu raka płuca w porównaniu do mężczyzn, którzy zostali losowo przydzieleni do grupy bez badań przesiewowych.9
Ważne jest zaznaczenie, że badanie przesiewowe z użyciem zdjęć rentgenowskich klatki piersiowej i/lub badań cytologicznych plwociny nie zmniejsza śmiertelności z powodu raka płuca w populacji ogólnej ani u osób, które kiedykolwiek paliły.10 Biorąc pod uwagę obfitość i spójność dowodów, a także brak korzyści zaobserwowanych w badaniu PLCO, właściwe jest stwierdzenie, że badania przesiewowe w kierunku raka płuca za pomocą zdjęć rentgenowskich klatki piersiowej i/lub badań cytologicznych plwociny, niezależnie od płci lub statusu palenia, nie zmniejszają śmiertelności z powodu raka płuca.11
Kto powinien przejść badanie przesiewowe?
Amerykańskie Towarzystwo Onkologiczne (ACS) zaleca coroczne badania przesiewowe w kierunku raka płuca za pomocą niskodawkowej tomografii komputerowej (LDCT) dla osób w wieku od 50 do 80 lat, które:12
- Palą obecnie lub paliły w przeszłości
- Mają co najmniej 20 paczkolat historii palenia (np. paczka dziennie przez 20 lat lub pół paczki dziennie przez 40 lat)
- Obecnie palą lub rzuciły palenie w ciągu ostatnich 15 lat
Grupa zadaniowa U.S. Preventive Services Task Force (USPSTF) również zaleca coroczne badania przesiewowe w kierunku raka płuca za pomocą LDCT u osób dorosłych w wieku od 50 do 80 lat, które mają 20 paczkolat historii palenia i obecnie palą lub rzuciły palenie w ciągu ostatnich 15 lat.14
Badania przesiewowe powinny zostać przerwane, gdy osoba nie pali od 15 lat lub rozwinie problem zdrowotny, który znacznie ogranicza oczekiwaną długość życia lub zdolność lub chęć do przeprowadzenia leczenia chirurgicznego raka płuca z intencją wyleczenia.15
Badania przesiewowe nie są zalecane dla osób, które mają słabą czynność płuc lub inne poważne schorzenia, które utrudniałyby operację. Może to dotyczyć osób, które potrzebują ciągłej suplementacji tlenem, doświadczyły niewyjaśnionej utraty wagi w ciągu ostatniego roku, niedawno odkrztusiły krew lub miały tomografię komputerową klatki piersiowej w ciągu ostatniego roku.16
Leczenie raka płuca wykrytego w badaniu przesiewowym
Leczenie raka płuca zależy od kilku czynników, w tym typu raka płuca, jego wielkości oraz tego, czy się rozprzestrzenił (stadium). Zależy to również od ogólnego stanu zdrowia pacjenta.17 Wcześniejsze wykrycie raka płuca pozwala specjalistom na zastosowanie bardziej skutecznych metod leczenia.18
Opcje leczenia dla wczesnych stadiów raka płuca
Wczesne wykrycie raka płuca znacząco zwiększa szanse na skuteczne leczenie. Dla pacjentów ze wczesnym stadium raka płuca (stadium I lub II), opcje leczenia często obejmują:
- Operację chirurgiczną – Często jest standardem opieki dla osób z rakiem płuca. Jeśli rak jest wykryty we wczesnym stadium, gdy jest mały i przed rozprzestrzenieniem się, istnieją większe szanse na jego skuteczne leczenie.19 Operacja może obejmować usunięcie części płuca lub całego płuca. Podczas operacji chirurg może również usunąć węzły chłonne z klatki piersiowej w celu sprawdzenia, czy zawierają komórki nowotworowe.20
- Stereotaktyczna radioterapia ciała (SBRT) – Jest to intensywna forma radioterapii, która może być stosowana, gdy operacja nie jest możliwa ze względu na stan zdrowia pacjenta.21
- Chemioterapia – Może być stosowana przed operacją w celu zmniejszenia guza lub po operacji, aby zniszczyć pozostałe komórki nowotworowe.22
Badania wykazały, że około 50% osób (lub 1 na 2) diagnozowanych z rakiem płuca poprzez coroczne badania przesiewowe jest diagnozowanych we wczesnym stadium, w porównaniu do około 28% wszystkich osób diagnozowanych z rakiem płuca we wczesnym stadium.24
Opcje leczenia dla zaawansowanego raka płuca
W przypadku bardziej zaawansowanych stadiów raka płuca (stadium III i IV), opcje leczenia mogą obejmować:
- Radioterapia – Leczy raka za pomocą silnych wiązek energii.25 Zaawansowane metody radioterapii, takie jak radioterapia z modulacją intensywności wiązki (IMRT), wykorzystują zaawansowaną technologię do dostarczania precyzyjnych dawek promieniowania do guza lub określonych obszarów w obrębie guza, dostosowując się do jego trójwymiarowego kształtu.26
- Chemioterapia – Wykorzystuje leki do niszczenia komórek nowotworowych.27 Chemioterapia dostarcza silne leki, które zabijają komórki nowotworowe. Często jest to kombinacja wielu leków zaprojektowanych w celu zatrzymania wzrostu komórek nowotworowych.28
- Terapia celowana – Wykorzystuje leki, które atakują określone substancje chemiczne w komórkach nowotworowych.29 U niektórych osób z niedrobnokomórkowym rakiem płuca (NDRP), komórki nowotworowe płuc mają specyficzne zmiany (mutacje), które pomagają nowotworowi rosnąć. Specjalne leki celują w te mutacje, aby spowolnić lub zniszczyć komórki nowotworowe.30
- Immunoterapia – Pomaga układowi odpornościowemu organizmu w zwalczaniu komórek nowotworowych.31 Immunoterapia ujawnia komórki nowotworowe układowi odpornościowemu, dzięki czemu własny organizm może walczyć z nowotworem.32
Dla pacjentów z zaawansowanym (przerzutowym) niedrobnokomórkowym rakiem płuca, leczenie często rozpoczyna się od kompleksowych badań biomarkerów i opracowania spersonalizowanego planu leczenia.35
Resekcja chirurgiczna
Resekcja chirurgiczna jest ogólnie uważana za obecną metodę leczenia z wyboru dla pacjentów z niedrobnokomórkowym rakiem płuca (NDRP) w stadium I lub II.36 Operacje chirurgiczne, które mogą być przeprowadzane w leczeniu raka płuca, obejmują:
- Lobektomia – usunięcie jednego płata płuca
- Resekcja klinowa – usunięcie małej części płuca zawierającej guz i niewielkiej ilości otaczającej tkanki
- Segmentektomia – usunięcie większej części płuca, ale nie całego płata
- Resekcja mankietowa lub lobektomia mankietowa
- Pneumonektomia – usunięcie całego płuca
Chirurgia robotyczna lub wspomagana robotem oraz torakoskopia wideo-asystowana (VATS) umożliwiają chirurgowi przeprowadzanie niektórych operacji z większą precyzją, elastycznością i kontrolą.38 Zastosowanie minimalnie inwazyjnych podejść do chirurgii raka płuca, w tym chirurgii wideo-asystowanej i wspomaganej robotem, konsekwentnie wykazało poprawę wyników krótkoterminowych w porównaniu z chirurgią otwartą.39
Radioterapia
Radioterapia wykorzystuje promieniowanie o wysokiej energii (podobne do promieni rentgenowskich) do zabicia raka.40 Dostępne są różne rodzaje radioterapii w leczeniu raka płuca:
- Brachyterapia – umieszcza materiał radioaktywny wewnątrz ciała w celu leczenia raka.41
- Radioterapia z modulacją intensywności wiązki (IMRT) – wykorzystuje zaawansowaną technologię do dostarczania precyzyjnych dawek promieniowania do guza lub określonych obszarów w obrębie guza, które dostosowują się do jego trójwymiarowego kształtu.42
- Stereotaktyczna radioterapia – wykorzystuje skoncentrowane, wysokodawkowe wiązki promieniowania do celowania w dobrze zdefiniowany guz z różnych kątów.43
Radioterapia może być stosowana w monoterapii lub w połączeniu z innymi metodami leczenia, takimi jak operacja czy chemioterapia, w zależności od stadium raka płuca.44
Chemioterapia i terapie systemowe
Chemioterapia wykorzystuje specjalne leki, najczęściej wprowadzane bezpośrednio do żyły, do zabijania komórek nowotworowych, a także do zatrzymania ich wzrostu i podziału.45 Terapie systemowe w leczeniu raka płuca mogą obejmować:
- Tradycyjna chemioterapia – Leki atakujące szybko rosnące komórki, co jest cechą charakterystyczną nowotworów.
- Terapia celowana – Wykorzystuje leki, które celują w specyficzne obszary wewnątrz komórek nowotworowych, oszczędzając zdrowe komórki.46 Ostatnio naukowcy zauważyli, że wzrost niektórych nowotworów płuc jest napędzany przez zmutowane receptory czynników wzrostu.47
- Immunoterapia – Ten rodzaj leczenia nie atakuje bezpośrednio raka. Zamiast tego wzmacnia własny układ odpornościowy pacjenta, aby skuteczniej atakował komórki nowotworowe.48 Wiele nowotworów płuc rośnie i rozprzestrzenia się, ponieważ aktywnie unikają układu odpornościowego. Inhibitory punktów kontrolnych układu odpornościowego to przeciwciała, które blokują zdolność komórek nowotworowych do unikania układu odpornościowego, sprzyjając tym samym atakowi immunologicznemu.49
Leczenie specyficznych typów raka płuca
Leczenie niedrobnokomórkowego raka płuca (NDRP) różni się w zależności od stadium, histologii (płaskonabłonkowa vs. niepłaskonabłonkowa, zwykle gruczolakorak) oraz wyników badań biomarkerów genetycznych i immunoterapeutycznych.51
U pacjentów z NDRP w stadium I do II zwykle proponuje się kombinację trzech metod leczenia:
- Operacja chirurgiczna, która może obejmować całkowitą resekcję guza (zwykle stadium I i II), oraz dyssekcję węzłów chłonnych śródpiersia lub pobieranie próbek węzłów chłonnych
- Radioterapia
- Chemioterapia adjuwantowa oparta na platynie
U pacjentów z NDRP w stadium IV zaleca się opiekę paliatywną i immunoterapię z lub bez chemioterapii opartej na platynie.53
W przypadku drobnokomórkowego raka płuca (DRP) o ograniczonym stadium, standardem opieki jest chemioterapia etopozydem (Etopophos) plus cisplatyną i jednoczesna radioterapia klatki piersiowej, z resekcją chirurgiczną oferowaną wybranym pacjentom.54
U pacjentów z DRP w rozległym stadium należy zaoferować od czterech do sześciu cykli jednego z kilku schematów chemioterapii/immunoterapii skojarzonej z podtrzymującą immunoterapią.55
Korzyści i ryzyko związane z badaniami przesiewowymi
Korzyści z badań przesiewowych
Główną korzyścią z badań przesiewowych jest wykrycie raka wcześniej, gdy istnieje większa szansa na skuteczne leczenie.56 Badania przesiewowe w kierunku raka płuca z użyciem LDCT wykazały następujące korzyści:
- Zmniejszenie śmiertelności – Badania wykazały, że coroczne badania przesiewowe z użyciem LDCT mogą zmniejszyć ryzyko śmierci z powodu raka płuca o 20%.57
- Wczesne wykrycie – Badania przesiewowe w kierunku raka płuca wykrywają ponad połowę przypadków raka płuca we wczesnym stadium, gdy jest on bardziej wyleczalny, w porównaniu do tylko około 25% bez badań przesiewowych.58
- Więcej opcji leczenia – Pacjenci z wczesnym stadium raka płuca często mają więcej możliwości wyboru spośród operacji, radioterapii i chemioterapii.59
- Poprawa wskaźników przeżycia – Wykrywając raka płuca we wczesnym stadium, interwencje lecznicze mogą być wdrożone niezwłocznie, co prowadzi do lepszych wskaźników przeżycia i poprawy długoterminowej prognozy.60
Ryzyko związane z badaniami przesiewowymi
Badania przesiewowe w kierunku raka płuca wiążą się również z pewnymi ryzykami, które należy wziąć pod uwagę:
- Fałszywie dodatnie wyniki – Może prowadzić do niepotrzebnych dodatkowych badań. W badaniu NLST prawie jedna czwarta osób, które miały coroczne badania przesiewowe LDCT przez trzy lata, miała nieprawidłowy wynik testu, a ponad 95% nieprawidłowych wyników było „fałszywie dodatnich”, co oznacza, że nie reprezentowały one raka. Jednak te osoby nadal wymagały jakiegoś rodzaju dalszej obserwacji, zwykle tylko więcej badań obrazowych.62
- Przeoczenie raka – Fałszywie ujemne wyniki mogą wystąpić.63
- Nadmierna diagnoza – Czasami wykrywany jest wolno rosnący rak, który mógłby w przeciwnym razie pozostać niezdiagnozowany, ale także nie prowadzić do choroby lub śmierci.64
- Narażenie na promieniowanie – Zdjęcia rentgenowskie klatki piersiowej i tomografia komputerowa narażają klatkę piersiową na promieniowanie.65 Chociaż skany LDCT wykorzystują niższe dawki promieniowania niż te stosowane w tradycyjnych skanach CT, roczne narażenie na promieniowanie stwarza potencjalne zagrożenia dla zdrowia.66
- Kwestie psychologiczne – Jak w przypadku każdego badania przesiewowego, mogą pojawić się problemy związane z niepokojem i stresem.67
- Znalezienie raka, który jest zbyt zaawansowany, aby go wyleczyć – Zaawansowane raki płuc, takie jak te, które się rozprzestrzeniły, mogą nie reagować dobrze na leczenie, więc znalezienie tych nowotworów w teście przesiewowym w kierunku raka płuca może nie poprawić ani nie wydłużyć życia.68
Aby zminimalizować te ryzyka, badania przesiewowe są zalecane tylko dla osób z grupy wysokiego ryzyka. Pacjenci powinni porozmawiać ze swoim lekarzem, aby dowiedzieć się więcej o korzyściach i ryzykach związanych z badaniami przesiewowymi w kierunku raka płuca.70
Integracja badań przesiewowych w kompleksową opiekę nad pacjentem
Proces badania przesiewowego
Badanie przesiewowe w kierunku raka płuca powinno być częścią programu opieki i nie powinno być wykonywane jako autonomiczny test. Biorąc pod uwagę wysoki odsetek wyników fałszywie dodatnich i dalsze postępowanie, które następuje w przypadku wielu pacjentów, ryzyko i korzyści z badań przesiewowych w kierunku raka płuca powinny być omówione z osobą przed wykonaniem badania LDCT.71
Proces badania przesiewowego w kierunku raka płuca zwykle obejmuje następujące kroki:
- Konsultacja – Pacjenci spotykają się z lekarzem, aby omówić ryzyko i korzyści związane z badaniem przesiewowym. Brane są pod uwagę osobiste czynniki ryzyka pacjenta, a lekarz i pacjent współpracują, aby podjąć decyzję.72
- Badanie LDCT – Jeśli pacjent zdecyduje się na badanie przesiewowe, przechodzi niskodawkową tomografię komputerową. Podczas badania pacjent musi leżeć na stole CT i wstrzymać oddech na około 10-15 sekund, podczas gdy wykonywane są obrazy.73
- Interpretacja wyników – Skan LDCT jest czytany przez dedykowanego radiologaklatki piersiowej, a wyniki są zgłaszane bezpośrednio do lekarza.74
- Dalsze postępowanie – W zależności od wyników, lekarz może zalecić dodatkowe badania lub powtórzyć skan CT w późniejszym terminie, aby zobaczyć, czy zmienia się on w czasie.75
Multidyscyplinarne podejście do opieki
Zaleca się, aby instytucje przeprowadzające badania przesiewowe w kierunku raka płuca stosowały podejście multidyscyplinarne, które może obejmować takie specjalności jak radiologia, medycyna pulmonologiczna, medycyna wewnętrzna, onkologia klatki piersiowej i chirurgia klatki piersiowej.78
Jeśli badanie przesiewowe wykaże nieprawidłowości, multidyscyplinarny zespół specjalistów ds. raka płuca współpracuje, aby:
- Ocenić wyniki – Jeśli guzki płucne zostaną znalezione, zespół może przeprowadzić dalsze testy i biopsję, aby określić, czy jest to faktycznie rak, lub zlecić powtórzenie skanów CT w zalecanych odstępach czasu. Decyzje te są oparte na wielkości, charakterze i liczbie znalezionych guzków.79
- Opracować plan leczenia – Jeśli zostanie potwierdzony rak płuca, zespół opracuje skoordynowany i dokładny plan leczenia, wykorzystując terapię lekową, radioterapię, chirurgię onkologiczną lub kombinację tych metod leczenia.80
- Zapewnić wsparcie – Pacjenci mają dostęp do nawigatorów pielęgniarek onkologicznych i wyspecjalizowanych pielęgniarek praktyków, którzy towarzyszą im na każdym etapie procesu.81
Znaczenie zwiększania udziału w badaniach przesiewowych
Pomimo szerokich zaleceń ze strony prawie wszystkich paneli eksperckich, badania przesiewowe w kierunku raka płuca zostały słabo przyjęte. W rzeczywistości szacuje się, że tylko około 15 procent uprawnionych kandydatów zostało przebadanych.84
Inicjatywy mające na celu zwiększenie udziału w badaniach przesiewowych w kierunku raka płuca mogą obejmować:
- Edukacja publiczna – Informowanie społeczeństwa o korzyściach z wczesnego wykrywania raka płuca oraz o dostępności badań przesiewowych.
- Integracja poradnictwa dotyczącego zaprzestania palenia – Osoby, które poddają się badaniom przesiewowym, a które nadal palą, powinny mieć dostęp do poradnictwa dotyczącego zaprzestania palenia podczas wizyty w klinice. Pacjentom, którzy obecnie palą i są zainteresowani rzuceniem palenia, zostaną przedstawione opcje leczenia w celu zaprzestania palenia.85
- Nawigacja pacjenta – Programy nawigacji pacjenta mogą pomóc pacjentom poruszać się po systemie opieki zdrowotnej i zapewnić terminową opiekę.86
- Zwiększony dostęp – Zmniejszenie barier, takich jak koszty, dostępność lub strach przed procesem badań przesiewowych.87
Zaprzestanie palenia zmniejsza zachorowalność i śmiertelność u pacjentów z rakiem płuca, jednak żadne randomizowane badania kontrolowane nie porównywały konkretnych interwencji zaprzestania palenia w tej populacji.89 Pomoc w zaprzestaniu palenia w połączeniu z badaniami przesiewowymi CT była związana ze zmniejszeniem śmiertelności spowodowanej rakiem płuca i potencjałem do poprawy wskaźnika efektywności kosztowej badań przesiewowych.90
Przyszłość badań przesiewowych w kierunku raka płuca
Nowe technologie i metody
Badacze stale pracują nad rozwojem nowych metod badań przesiewowych i diagnostycznych, które mogą poprawić wczesne wykrywanie raka płuca:
- Biomarkery – Nasze kompleksowe menu testów markerów nowotworowych może być wykorzystywane do diagnostyki pomocniczej i różnicowej, a także do przewidywania możliwych typów patologicznych raka płuca. Ponadto nasze testy markerów nowotworowych mogą pomóc w ocenie odpowiedzi na terapię, choroby resztkowej po leczeniu i nawrotu choroby.91
- Testy inhalacyjne i moczu – Badacze twierdzą, że opracowali nowy sposób wykrywania raka płuca w jego najwcześniejszych stadiach przy użyciu inhalatora i prostego badania moczu. Ten nowy test przesiewowy w kierunku raka płuca został przetestowany na modelu mysim podczas tego badania. Zespół badawczy podobno planuje następnie przetestować czujniki na ludzkich próbkach biopsyjnych, a ostatecznie przeprowadzić próby kliniczne na ludziach.92
- Rozszerzone kryteria badań przesiewowych – Autorzy badają ryzyko zachorowania na raka z powodu promieniowania jonizującego i stwierdzają, że stosunek korzyści do ryzyka napromieniowania jest bardzo korzystny dla obecnych niskodawkowych tomografii komputerowych w badaniach przesiewowych w kierunku raka płuca. Ich wyniki podkreślają znaczenie stosowania nowoczesnych technologii CT, utrzymywania niskich wskaźników dalszej obserwacji oraz minimalizowania dawek promieniowania zarówno podczas badań przesiewowych, jak i podczas dalszej obserwacji.93
Badania kliniczne i innowacje
Badania kliniczne odgrywają kluczową rolę w rozwoju nowych opcji leczenia raka płuca:
- Badanie nowych leków – Naukowcy pracują nad opracowaniem nowych leków, w tym koniugatów przeciwciało-lek (ADC) do celowania w biomarkery możliwe do działania, takie jak receptor ludzkiego naskórkowego czynnika wzrostu 2 (HER2).95
- Zaawansowana immunoterapia – Immunoterapie mają na celu celowanie w punkty kontrolne układu odpornościowego, które są wykorzystywane przez raka, aby uniknąć lub stłumić zdolność układu odpornościowego do rozpoznawania i niszczenia komórek nowotworowych.96
- Leczenie skojarzone – W związku z wprowadzeniem badań przesiewowych w kierunku raka płuca oczekuje się, że więcej przypadków zostanie odkrytych we wcześniejszym stadium. Dlatego obecna mieszanka terapii chirurgii, radioterapii i chemioterapii prawdopodobnie zmieni się na mniej inwazyjne i łagodniejsze metody. Chirurgia przez dziurkę od klucza, stereotaktyczna radioterapia i techniki ablacji miejscowej oraz ich kombinacje mogą stać się ważniejsze.97
Wiele nowych terapii koncentrowało się na postępach w opiece nad pacjentami z przerzutami z wysoką niezaspokojoną potrzebą medyczną, jednak priorytetem stało się wprowadzenie leczenia na wcześniejszych etapach raka płuca. Aby naprawdę wyleczyć raka, musimy leczyć wcześniej, aby zmaksymalizować potencjał długoterminowej remisji choroby i możliwość wyleczenia.99
Wpływ na zdrowie publiczne i strategie prewencji
Badania przesiewowe w kierunku raka płuca mają znaczący wpływ na zdrowie publiczne:
- Zmniejszenie śmiertelności – Od czasu wprowadzenia badań przesiewowych pod kątem raka płuca dla osób uważanych za zagrożone rakiem płuca, uratowano ponad 10 000 amerykańskich istnień ludzkich.100
- Opłacalność – Badania przesiewowe w kierunku raka płuca mają potencjał do zmniejszenia kosztów. Jednak zakres oszczędności zależy w dużej mierze od sposobu wdrożenia programów badań przesiewowych.101
- Strategie zapobiegania – Najlepszym sposobem zapobiegania rakowi płuca jest rzucenie palenia. Osoby, które rzuciły palenie na ponad 15 lat, mają 80-90% redukcję ryzyka zachorowania na raka płuca w porównaniu do osób, które nadal palą.102
Integracja zaprzestania palenia z badaniami przesiewowymi może dodatkowo poprawić wyniki. W badaniu National Lung Screening Trial, aktualni palacze, którzy przeszli badania przesiewowe, które były podejrzane, ale nie diagnostyczne dla raka płuca, znacznie częściej rzucali palenie w ciągu 1 roku.104
Podsumowując, badania przesiewowe w kierunku raka płuca z użyciem niskodawkowej tomografii komputerowej (LDCT) stanowią obiecującą strategię zmniejszenia obciążenia rakiem płuca poprzez wczesne wykrywanie, gdy leczenie jest bardziej skuteczne. Jednak szersze wdrożenie badań przesiewowych wymaga skoordynowanych wysiłków w zakresie edukacji publicznej, łatwego dostępu i integracji z kompleksowymi usługami opieki zdrowotnej, w tym poradnictwem dotyczącym zaprzestania palenia.
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Lung Cancer Screeninghttps://pmc.ncbi.nlm.nih.gov/articles/PMC6467530/
Lung cancer is the leading cause of cancer-related mortality in the United States and worldwide. In 2011, it is estimated that 156,900 deaths (85,600 in men, 71,300 in women) from lung cancer will occur in the United States. Five-year survival rates for lung cancer are only approximately 15.6%, partly because most patients have advanced-stage lung cancer at initial diagnosis. […] These facts, combined with the success of screening in improving outcomes in cervical, colon, and breast cancers, have been the impetus for studies to develop an effective lung cancer screening test. Ideally, effective screening will lead to earlier detection of lung cancer (before patients have symptoms and when treatment is more likely to be effective) and will decrease mortality. Currently, most lung cancer is diagnosed clinically when patients present with symptoms (such as cough, chest pain, weight loss); unfortunately, patients with these symptoms usually have advanced lung cancer.
- #2 Lung Cancerhttps://www.siemens-healthineers.com/clinical-specialities/oncology/cancer-types/lung-cancer
Detecting early-stage lung cancer with low-dose CT scanning can dramatically improve the long-term survival rate of lung cancer patients. A study shows that patients diagnosed with lung cancer by low-dose CT screening have a 20-year survival rate of 81%. If diagnosed in the earliest Stage I and if adequate therapy has been applied, long-term survival was 95%. This emphasizes the benefit to establish screening programs for earlier detection. […] With the implementation of lung cancer screening protocols for at-risk patients, lung cancer can be detected at an early stage which could dramatically improve chances for survival. As a result, there will be an increasing focus on image-guided minimally invasive treatment options with curative intent. […] Confident diagnosis and accurate staging of lung cancer are essential for adequate therapy selection, precise treatment planning and ultimately key for therapy success.
- #3 Lung cancer screening – Mayo Clinichttps://www.mayoclinic.org/tests-procedures/lung-cancer-screening/about/pac-20385024
Lung cancer screening is a process that’s used to detect the presence of lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are longtime smokers and who don’t have any signs or symptoms of lung cancer. […] Doctors use a low-dose computerized tomography (LDCT) scan of the lungs to look for lung cancer. If lung cancer is detected at an early stage, it’s more likely to be cured with treatment. […] The goal of lung cancer screening is to detect lung cancer at a very early stage when it’s more likely to be cured. By the time lung cancer signs and symptoms develop, the cancer is usually too advanced for curative treatment. Studies show lung cancer screening reduces the risk of dying of lung cancer. […] Screening is generally not recommended for those who have poor lung function or other serious conditions that would make surgery difficult. This might include people who need continuous supplemental oxygen, have experienced unexplained weight loss in the past year, have coughed up blood recently or have had a chest CT scan in the last year.
- #4 Lung Cancer Screening – NCIhttps://www.cancer.gov/types/lung/patient/lung-screening-pdq
Screening is looking for cancer before a person has any symptoms. This can help find cancer at an early stage. When abnormal tissue or cancer is found early, it may be easier to treat. […] Screening with LDCT scans has been shown to decrease the risk of dying from lung cancer in heavy smokers. […] Screening with chest x-rays and/or sputum cytology does not decrease the risk of dying from lung cancer. […] Screening tests have risks. […] Finding lung cancer may not improve health or help you live longer. […] False-negative test results can occur. […] False-positive test results can occur. […] Chest x-rays and CT scans expose the chest to radiation. […] Talk to your doctor about your risk for lung cancer and your need for screening tests.
- #5 Lung cancer screening – Mayo Clinichttps://www.mayoclinic.org/tests-procedures/lung-cancer-screening/about/pac-20385024
Lung cancer screening is a process that’s used to detect the presence of lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are longtime smokers and who don’t have any signs or symptoms of lung cancer. […] Doctors use a low-dose computerized tomography (LDCT) scan of the lungs to look for lung cancer. If lung cancer is detected at an early stage, it’s more likely to be cured with treatment. […] The goal of lung cancer screening is to detect lung cancer at a very early stage when it’s more likely to be cured. By the time lung cancer signs and symptoms develop, the cancer is usually too advanced for curative treatment. Studies show lung cancer screening reduces the risk of dying of lung cancer. […] Screening is generally not recommended for those who have poor lung function or other serious conditions that would make surgery difficult. This might include people who need continuous supplemental oxygen, have experienced unexplained weight loss in the past year, have coughed up blood recently or have had a chest CT scan in the last year.
- #6 Screening for Lung Cancer | Lung Cancer | CDChttps://www.cdc.gov/lung-cancer/screening/index.html
The only recommended screening test for lung cancer is low-dose computed tomography (also called a low-dose CT scan, or LDCT). […] Lung cancer screening is recommended only for adults who are at high risk for developing the disease because of their smoking history and age. […] Screening means testing for a disease when there are no symptoms or history of that disease. Doctors recommend a screening test to find a disease early, when treatment may work better. […] If you are thinking about getting screened, talk to your doctor. If lung cancer screening is right for you, your doctor can refer you to a high-quality screening facility. […] Lung cancer screening can help find it early, when treatment may work better. […] Many people who use tobacco become addicted to nicotine, a drug found naturally in tobacco. This can make it hard to quit. Most people who use tobacco try to quit several times before they succeed. […] Most insurance plans and Medicare help pay for recommended lung cancer screening tests.
- #7 Lung Cancer Screening – Lung Cancer | UCLA Health Jonsson Comprehensive Cancer Centerhttps://www.uclahealth.org/cancer/cancer-services/lung-cancer/diagnosis-treatment/lung-cancer-screening
A screening for lung cancer can detect long before you realize its there, and finding lung cancer early allows your care team to deliver timely lifesaving treatments. […] Low-dose CT (LDCT) screening combines an X-ray machine and sophisticated computers to create detailed images of your chest. LDCT is very sensitive and precise. This technology detects even the smallest nodule on the lungs while using 90% less radiation than a traditional chest imaging scan.
- #8 Lung Cancer Screening (PDQ®) – NCIhttps://www.cancer.gov/types/lung/hp/lung-screening-pdq
Two randomized trials have reported statistically significant reductions in lung cancer mortality associated with low-dose computed tomography (LDCT) screening. One trial reported that screening higher-risk individuals (30+ pack-years and either current smokers or quit within the past 15 years) aged 55 to 74 years three times, once annually, with LDCT reduced lung cancer mortality by 20% (95% confidence interval [CI], 6.8%26.7%; P = .004) and all-cause mortality by 6.7% (95% CI, 1.2%13.6%; P = .02) over screening with chest radiographs. […] The other trial reported that among high-risk current and former smokers, men who were randomly assigned to four rounds of LDCT screening had a 24% reduction (95% CI, 6%39%) in lung cancer mortality, compared with men who were randomly assigned to no screening.
- #9 Lung Cancer Screening (PDQ®) – NCIhttps://www.cancer.gov/types/lung/hp/lung-screening-pdq
Two randomized trials have reported statistically significant reductions in lung cancer mortality associated with low-dose computed tomography (LDCT) screening. One trial reported that screening higher-risk individuals (30+ pack-years and either current smokers or quit within the past 15 years) aged 55 to 74 years three times, once annually, with LDCT reduced lung cancer mortality by 20% (95% confidence interval [CI], 6.8%26.7%; P = .004) and all-cause mortality by 6.7% (95% CI, 1.2%13.6%; P = .02) over screening with chest radiographs. […] The other trial reported that among high-risk current and former smokers, men who were randomly assigned to four rounds of LDCT screening had a 24% reduction (95% CI, 6%39%) in lung cancer mortality, compared with men who were randomly assigned to no screening.
- #10 Lung Cancer Screening (PDQ®) – NCIhttps://www.cancer.gov/types/lung/hp/lung-screening-pdq
Based on solid evidence, screening with chest x-ray and/or sputum cytology does not reduce mortality from lung cancer in the general population or in ever-smokers. […] Given the abundance and consistency of evidence, as well as the lack of benefit observed in the PLCO trial, it is appropriate to conclude that lung cancer screening with chest x-ray and/or sputum cytology, regardless of sex or smoking status, does not reduce lung cancer mortality.
- #11 Lung Cancer Screening (PDQ®) – NCIhttps://www.cancer.gov/types/lung/hp/lung-screening-pdq
Based on solid evidence, screening with chest x-ray and/or sputum cytology does not reduce mortality from lung cancer in the general population or in ever-smokers. […] Given the abundance and consistency of evidence, as well as the lack of benefit observed in the PLCO trial, it is appropriate to conclude that lung cancer screening with chest x-ray and/or sputum cytology, regardless of sex or smoking status, does not reduce lung cancer mortality.
- #12 Lung Cancer Early Detection | Lung Cancer Screening | American Cancer Societyhttps://www.cancer.org/cancer/types/lung-cancer/detection-diagnosis-staging/detection.html
The American Cancer Society recommends yearly screening for lung cancer with a low-dose CT (LDCT) scan for people ages 50 to 80 years who: Smoke or used to smoke AND Have at least a 20 pack-year history of smoking. […] The main benefit of screening is finding the cancer earlier and thus, lowering the chance of dying from lung cancer. […] LDCT scans can also find things that turn out not to be cancer, but that still have to be checked out with more tests to know what they are. […] To get the most benefit from screening, people need to be in fairly good health. For example, they need to be healthy enough to have surgery and receive other treatments if lung cancer is found. […] It’s important to talk to your doctor about all your health issues when deciding if lung cancer screening is right for you.
- #13 Lung Cancer Screening Guidelines | American Cancer Societyhttps://www.cancer.org/health-care-professionals/american-cancer-society-prevention-early-detection-guidelines/lung-cancer-screening-guidelines.html
People who currently smoke or formerly smoked are at higher risk for lung cancer. The American Cancer Society recommends yearly lung cancer screening with a low-dose CT scan (LDCT) for some of these people. […] Before deciding to be screened, people should have a discussion with a healthcare professional about the purpose of screening and how it is done, as well as the benefits, limits, and possible harms of screening. […] People should not be screened if they have serious health problems that will likely limit how long they will live, or if they wont be able to or wont want to get treatment if lung cancer is found. […] The ACS Early Science Detection Science team oversaw this systematic review to better understand lung cancer incidence, risk, and mortality and found that people who formerly smoked remain at risk for lung cancer well beyond 15 years after they stop using tobacco and that the risks decline gradually.
- #14 Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforcehttps://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. […] Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. […] Lung cancer can be treated with surgery, chemotherapy, radiation therapy, targeted therapies, immunotherapy, or combinations of these treatments. […] Surgical resection is generally considered the current treatment of choice for patients with stage I or II nonsmall cell lung cancer (NSCLC). […] The USPSTF recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction modelbased screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care. […] The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation.
- #15 Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforcehttps://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. […] Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. […] Lung cancer can be treated with surgery, chemotherapy, radiation therapy, targeted therapies, immunotherapy, or combinations of these treatments. […] Surgical resection is generally considered the current treatment of choice for patients with stage I or II nonsmall cell lung cancer (NSCLC). […] The USPSTF recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction modelbased screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care. […] The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation.
- #16 Lung cancer screening – Mayo Clinichttps://www.mayoclinic.org/tests-procedures/lung-cancer-screening/about/pac-20385024
Lung cancer screening is a process that’s used to detect the presence of lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are longtime smokers and who don’t have any signs or symptoms of lung cancer. […] Doctors use a low-dose computerized tomography (LDCT) scan of the lungs to look for lung cancer. If lung cancer is detected at an early stage, it’s more likely to be cured with treatment. […] The goal of lung cancer screening is to detect lung cancer at a very early stage when it’s more likely to be cured. By the time lung cancer signs and symptoms develop, the cancer is usually too advanced for curative treatment. Studies show lung cancer screening reduces the risk of dying of lung cancer. […] Screening is generally not recommended for those who have poor lung function or other serious conditions that would make surgery difficult. This might include people who need continuous supplemental oxygen, have experienced unexplained weight loss in the past year, have coughed up blood recently or have had a chest CT scan in the last year.
- #17 Lung Cancer Screening | Cancer Research UKhttps://www.cancerresearchuk.org/about-cancer/lung-cancer/getting-diagnosed/screening
Lung cancer screening aims to find lung cancer early. This is when there are more treatment options available and there is the best chance of treating it successfully. […] Diagnosing lung cancer early means that treatment is more likely to work. […] Your treatment depends on several factors. These include what type of lung cancer you have, how big it is and whether it has spread (the stage). It also depends on your general health.
- #18 Lung Cancer Screening – Lung Cancer | UCLA Health Jonsson Comprehensive Cancer Centerhttps://www.uclahealth.org/cancer/cancer-services/lung-cancer/diagnosis-treatment/lung-cancer-screening
We use advanced technology to detect lung cancer before symptoms appear. An early diagnosis of lung cancer allows us to deliver more effective treatments. […] At UCLA Health, our specialists work together to give you an expert evaluation you can trust. When you choose UCLA Health for lung cancer screening, youll find: […] An early diagnosis of lung cancer allows us to destroy cancer when its most treatable. […] This approach, called precision medicine, allows us to offer more effective treatments. […] Our pulmonary and thoracic physicians use the latest imaging techniques to detect lung abnormalities in patients who are at risk for developing lung cancer. This thorough screening for lung cancer process enables us to deliver a diagnosis as early as possible so treatments will be more effective.
- #19 Lung Cancer Early Detection | Lung Cancer Screening | American Cancer Societyhttps://www.cancer.org/cancer/types/lung-cancer/detection-diagnosis-staging/detection.html
Regular chest x-rays have been studied as a screening test for people at higher risk for lung cancer, but they haven’t been shown to help most people live longer, and therefore they aren’t recommended for lung cancer screening. […] At present, a test known as a low-dose CT (LDCT) scan is used to screen people at higher risk (mainly because they smoke or used to smoke) for lung cancer. LDCT scans can help find abnormal areas in the lungs that may be cancer. Research has shown that unlike chest x-rays, yearly LDCT scans to screen people at higher risk of lung cancer can save lives. For these people, getting yearly LDCT scans before symptoms start helps lower the risk of dying from lung cancer. […] If lung cancer is found at an earlier stage, when it is small and before it has spread, it is more likely to be treated successfully. Lung cancer screening is recommended for certain people who smoke or used to smoke, but who don’t have any signs or symptoms.
- #20 Lung cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
If you’re diagnosed with lung cancer, you may have other tests to see if the cancer has spread. These tests help your healthcare team find out the extent of your cancer, also called the stage. […] Treatment for lung cancer usually begins with surgery to remove the cancer. If the cancer is very large or has spread to other parts of the body, surgery may not be possible. Treatment might start with medicine and radiation instead. […] Lung cancer surgery can involve removing a portion of the lung or the entire lung. […] If you have surgery, your surgeon also may remove lymph nodes from your chest to test them for cancer. […] Surgery may be an option if your cancer is only in the lungs. If you have a larger lung cancer, chemotherapy or radiation therapy may be used before surgery to shrink the cancer.
- #21 Lung cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
Radiation therapy treats cancer with powerful energy beams. […] Chemotherapy treats cancer with strong medicines. […] Stereotactic body radiotherapy is an intense radiation treatment. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. […] Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system to kill cancer cells. […] Palliative care is a special type of healthcare that helps you feel better when you have a serious illness. […] The use of palliative care with other proper treatments can help people with cancer feel better and live longer.
- #22 Lung cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
Radiation therapy treats cancer with powerful energy beams. […] Chemotherapy treats cancer with strong medicines. […] Stereotactic body radiotherapy is an intense radiation treatment. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. […] Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system to kill cancer cells. […] Palliative care is a special type of healthcare that helps you feel better when you have a serious illness. […] The use of palliative care with other proper treatments can help people with cancer feel better and live longer.
- #23 Screening & Early Detection | LUNGevity Foundationhttps://www.lungevity.org/lung-cancer-basics/screening-early-detection
Finding lung cancer early, when it is easiest to treat, can save lives. […] Early detection of lung cancer is defined as strategies that can detect lung cancer at a stage the extent of cancer in the body where surgery or stereotactic body radiation therapy (SBRT) can be offered with the goal of a cure. […] However, lung cancer is most easily and effectively treated when it is found at an early stage. […] For early-stage patients, treatment will be surgery or SBRT. For advanced-stage patients, treatment will begin, ideally after comprehensive biomarker testing and a personalized treatment plan is developed.
- #24 Lung Cancer Screening: Purpose, Procedure & Resultshttps://my.clevelandclinic.org/health/diagnostics/15031-lung-cancer-screening
Lung cancer screening increases the likelihood that if you do develop lung cancer, youll be diagnosed at an early stage when its more treatable. Studies suggest that over 50% of people (or 1 in 2) diagnosed with lung cancer through annual screening are diagnosed at an early stage, compared to about 28% of all people diagnosed with lung cancer at an early stage. […] Talk to your provider about whether youre at a higher risk for lung cancer and if you should get screened. It could save your life.
- #25 Lung cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
Radiation therapy treats cancer with powerful energy beams. […] Chemotherapy treats cancer with strong medicines. […] Stereotactic body radiotherapy is an intense radiation treatment. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. […] Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system to kill cancer cells. […] Palliative care is a special type of healthcare that helps you feel better when you have a serious illness. […] The use of palliative care with other proper treatments can help people with cancer feel better and live longer.
- #26 Lung Cancer Care | OhioHealthhttps://www.ohiohealth.com/lungcancer
Brachytherapy places radioactive material inside the body to treat cancer. […] Intensity-modulated radiation therapy (IMRT) uses advanced technology to deliver precise radiation doses to a tumor or specific areas within the tumor that conform to its 3D shape. […] Stereotactic radiotherapy uses focused, high-dose radiation beams to target a well-defined tumor from different angles. […] One of the newest and most aggressive options in cancer treatment today, interventional radiology targets and treats cancers that cannot be treated surgically by using heating, cooling or microwave energy to kill tumor cells.
- #27 Lung cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
Radiation therapy treats cancer with powerful energy beams. […] Chemotherapy treats cancer with strong medicines. […] Stereotactic body radiotherapy is an intense radiation treatment. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. […] Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system to kill cancer cells. […] Palliative care is a special type of healthcare that helps you feel better when you have a serious illness. […] The use of palliative care with other proper treatments can help people with cancer feel better and live longer.
- #28 Lung Cancer: Types, Stages, Symptoms, Diagnosis & Treatmenthttps://my.clevelandclinic.org/health/diseases/4375-lung-cancer
NSCLC that hasn’t spread and SCLC that’s limited to a single tumor can be eligible for surgery. Your surgeon might remove the tumor and a small amount of healthy tissue around it to make sure they don’t leave any cancer cells behind. […] Radiation uses high energy beams to kill cancer cells. It can be used by itself or to help make surgery more effective. […] Chemotherapy is often a combination of multiple medications designed to stop cancer cells from growing. […] In some people with NSCLC, lung cancer cells have specific changes (mutations) that help the cancer grow. Special drugs target these mutations to try to slow down or destroy cancer cells. […] Immunotherapy reveals cancer cells to your immune system so your own body can fight cancer. […] Some lung cancer treatments are used to relieve symptoms, like pain and difficulty breathing.
- #29 Lung cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
Radiation therapy treats cancer with powerful energy beams. […] Chemotherapy treats cancer with strong medicines. […] Stereotactic body radiotherapy is an intense radiation treatment. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. […] Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system to kill cancer cells. […] Palliative care is a special type of healthcare that helps you feel better when you have a serious illness. […] The use of palliative care with other proper treatments can help people with cancer feel better and live longer.
- #30 Lung Cancer: Types, Stages, Symptoms, Diagnosis & Treatmenthttps://my.clevelandclinic.org/health/diseases/4375-lung-cancer
NSCLC that hasn’t spread and SCLC that’s limited to a single tumor can be eligible for surgery. Your surgeon might remove the tumor and a small amount of healthy tissue around it to make sure they don’t leave any cancer cells behind. […] Radiation uses high energy beams to kill cancer cells. It can be used by itself or to help make surgery more effective. […] Chemotherapy is often a combination of multiple medications designed to stop cancer cells from growing. […] In some people with NSCLC, lung cancer cells have specific changes (mutations) that help the cancer grow. Special drugs target these mutations to try to slow down or destroy cancer cells. […] Immunotherapy reveals cancer cells to your immune system so your own body can fight cancer. […] Some lung cancer treatments are used to relieve symptoms, like pain and difficulty breathing.
- #31 Lung cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
Radiation therapy treats cancer with powerful energy beams. […] Chemotherapy treats cancer with strong medicines. […] Stereotactic body radiotherapy is an intense radiation treatment. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. […] Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system to kill cancer cells. […] Palliative care is a special type of healthcare that helps you feel better when you have a serious illness. […] The use of palliative care with other proper treatments can help people with cancer feel better and live longer.
- #32 Lung Cancer: Types, Stages, Symptoms, Diagnosis & Treatmenthttps://my.clevelandclinic.org/health/diseases/4375-lung-cancer
NSCLC that hasn’t spread and SCLC that’s limited to a single tumor can be eligible for surgery. Your surgeon might remove the tumor and a small amount of healthy tissue around it to make sure they don’t leave any cancer cells behind. […] Radiation uses high energy beams to kill cancer cells. It can be used by itself or to help make surgery more effective. […] Chemotherapy is often a combination of multiple medications designed to stop cancer cells from growing. […] In some people with NSCLC, lung cancer cells have specific changes (mutations) that help the cancer grow. Special drugs target these mutations to try to slow down or destroy cancer cells. […] Immunotherapy reveals cancer cells to your immune system so your own body can fight cancer. […] Some lung cancer treatments are used to relieve symptoms, like pain and difficulty breathing.
- #33https://www.mercy.net/service/lung-cancer/diagnosis-treatment/
While receiving a lung cancer diagnosis can be an extremely troubling event, there are treatment options available now that provide hope. […] Mercys team of cancer specialists has experience treating all types of lung cancer, including lung cancer that has spread or returned. Your treatment plan will depend on several important factors, including: […] Well develop a coordinated and thorough treatment plan to fight your lung cancer, by using medication therapy, radiation therapy, cancer surgery or a combination of these treatment methods. […] Also referred to simply as chemo, chemotherapy uses a range of different drugs, usually inserted directly into the vein, to kill cancer cells, as well as to stop them from growing and dividing. […] Targeted therapy uses drugs that aim for specific areas inside cancer cells, leaving your healthy cells alone.
- #34https://www.mercy.net/service/lung-cancer/diagnosis-treatment/
This type of drug treatment uses special medications to recruit your immune system to attack cancer once it recognizes its presence within your body. […] SBRT offers a more precise radiation delivery system while avoiding healthy tissue next to the tumor. […] Depending on the type and stage, lung cancer can be treated with surgery. […] Whenever possible, Mercy surgeons use minimally invasive robotic surgery with the goal of shorter hospital stays and reduced pain.
- #35 Screening & Early Detection | LUNGevity Foundationhttps://www.lungevity.org/lung-cancer-basics/screening-early-detection
Finding lung cancer early, when it is easiest to treat, can save lives. […] Early detection of lung cancer is defined as strategies that can detect lung cancer at a stage the extent of cancer in the body where surgery or stereotactic body radiation therapy (SBRT) can be offered with the goal of a cure. […] However, lung cancer is most easily and effectively treated when it is found at an early stage. […] For early-stage patients, treatment will be surgery or SBRT. For advanced-stage patients, treatment will begin, ideally after comprehensive biomarker testing and a personalized treatment plan is developed.
- #36 Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforcehttps://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. […] Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. […] Lung cancer can be treated with surgery, chemotherapy, radiation therapy, targeted therapies, immunotherapy, or combinations of these treatments. […] Surgical resection is generally considered the current treatment of choice for patients with stage I or II nonsmall cell lung cancer (NSCLC). […] The USPSTF recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction modelbased screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care. […] The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation.
- #37 Lung Cancer Care | OhioHealthhttps://www.ohiohealth.com/lungcancer
The OhioHealth lung cancer screening program uses a low-dose chest CT scan for early detection of lung cancer. […] Our multidisciplinary team of lung cancer experts work together to provide comprehensive treatment options. […] Whether we use surgery depends on the size and location of the tumor, as well as your overall health. Surgical procedures we offer for lung cancer include: Lobectomy, Wedge resection removal, Segmentectomy, Sleeve resection or sleeve lobectomy, Pneumonectomy. […] Robotic or robot-assisted surgery and video-assisted thoracic surgery enable your surgeon to perform some surgeries with more precision, flexibility and control. […] Our chemotherapy, immunotherapy and targeted therapies are highly individualized. […] We also offer targeted therapies. These drug treatments block the growth and spread of cancer by interfering with specific molecules that are involved in the growth, progression and spread of cancer.
- #38 Lung Cancer Care | OhioHealthhttps://www.ohiohealth.com/lungcancer
The OhioHealth lung cancer screening program uses a low-dose chest CT scan for early detection of lung cancer. […] Our multidisciplinary team of lung cancer experts work together to provide comprehensive treatment options. […] Whether we use surgery depends on the size and location of the tumor, as well as your overall health. Surgical procedures we offer for lung cancer include: Lobectomy, Wedge resection removal, Segmentectomy, Sleeve resection or sleeve lobectomy, Pneumonectomy. […] Robotic or robot-assisted surgery and video-assisted thoracic surgery enable your surgeon to perform some surgeries with more precision, flexibility and control. […] Our chemotherapy, immunotherapy and targeted therapies are highly individualized. […] We also offer targeted therapies. These drug treatments block the growth and spread of cancer by interfering with specific molecules that are involved in the growth, progression and spread of cancer.
- #39 Lung Cancer and Advances in Treatment, Surgery and Screening to Save Lives | Brown University Healthhttps://www.brownhealth.org/be-well/lung-cancer-and-advances-treatment-surgery-and-screening-save-lives
The use of minimally invasive approaches to lung cancer surgery, including video-assisted and robot-assisted surgery, has consistently been shown to improve short-term outcomes compared to open surgery. […] Many lung cancers grow and spread because they actively evade the immune system. Immune checkpoint inhibitors are antibodies which block the ability of the cancer cells to evade the immune system, thus fostering an immune attack. […] The goal of this approach is to foster immune attack so that a patients own immune system protects patients from metastatic spread, which can improve rates of cure. […] Lung cancer screening involves a low dose CT scan of the chest, which collects multiple images while the individual lies on a donut-shaped scanner table. […] Lung cancer screening with an annual low-dose CT improves survival by detecting these cancers at an early stage.
- #40 Treatment of Lung Cancer | Lung Cancer | CDChttps://www.cdc.gov/lung-cancer/treatment/index.html
Lung cancer can be treated in several ways. […] Treatment depends on the type of lung cancer and how far it has spread. […] People with non-small cell lung cancer can be treated with surgery. […] Lung cancer is treated in several ways, depending on the type of lung cancer and how far it has spread. People with non-small cell lung cancer can be treated with surgery, chemotherapy, radiation therapy, targeted therapy, or a combination of these treatments. People with small cell lung cancer are usually treated with radiation therapy and chemotherapy. […] Surgery: An operation in which doctors cut out the cancer. […] Chemotherapy: Use of special medicines to shrink or kill the cancer. The drugs can be pills you take or medicines given in your veins, or sometimes both. […] Radiation therapy: Use of high-energy rays (similar to x-rays) to kill the cancer.
- #41 Lung Cancer Care | OhioHealthhttps://www.ohiohealth.com/lungcancer
Brachytherapy places radioactive material inside the body to treat cancer. […] Intensity-modulated radiation therapy (IMRT) uses advanced technology to deliver precise radiation doses to a tumor or specific areas within the tumor that conform to its 3D shape. […] Stereotactic radiotherapy uses focused, high-dose radiation beams to target a well-defined tumor from different angles. […] One of the newest and most aggressive options in cancer treatment today, interventional radiology targets and treats cancers that cannot be treated surgically by using heating, cooling or microwave energy to kill tumor cells.
- #42 Lung Cancer Care | OhioHealthhttps://www.ohiohealth.com/lungcancer
Brachytherapy places radioactive material inside the body to treat cancer. […] Intensity-modulated radiation therapy (IMRT) uses advanced technology to deliver precise radiation doses to a tumor or specific areas within the tumor that conform to its 3D shape. […] Stereotactic radiotherapy uses focused, high-dose radiation beams to target a well-defined tumor from different angles. […] One of the newest and most aggressive options in cancer treatment today, interventional radiology targets and treats cancers that cannot be treated surgically by using heating, cooling or microwave energy to kill tumor cells.
- #43 Lung Cancer Care | OhioHealthhttps://www.ohiohealth.com/lungcancer
Brachytherapy places radioactive material inside the body to treat cancer. […] Intensity-modulated radiation therapy (IMRT) uses advanced technology to deliver precise radiation doses to a tumor or specific areas within the tumor that conform to its 3D shape. […] Stereotactic radiotherapy uses focused, high-dose radiation beams to target a well-defined tumor from different angles. […] One of the newest and most aggressive options in cancer treatment today, interventional radiology targets and treats cancers that cannot be treated surgically by using heating, cooling or microwave energy to kill tumor cells.
- #44https://www.missionhealth.org/specialties/oncology/lung-cancer
Lung cancer is one of the most common cancers, and is highly treatable. It can be treated through surgery, chemotherapy or radiation therapy. […] Lung cancer can be preventable and treatable. […] Effective treatment for lung cancer begins with a proper diagnosis. […] When you come to one of our hospitals for lung cancer treatment, you are treated with the utmost care and understanding from a multidisciplinary team of lung cancer specialists. […] Chemotherapy uses drugs to destroy cancer cells, and may be used by itself or in combination with radiation therapy and surgery. […] Lung surgery may be recommended to remove tumors, the affected lobe of the lung or, in some cases, the affected lung. […] Our radiation therapists specialize their treatments by tumor type, using radiation treatments, such as X-rays and focused ultrasound, to destroy cancer cells and shrink tumors. […] Finding lung cancer in its earliest stages is critical for producing more positive treatment outcomes.
- #45https://www.mercy.net/service/lung-cancer/diagnosis-treatment/
While receiving a lung cancer diagnosis can be an extremely troubling event, there are treatment options available now that provide hope. […] Mercys team of cancer specialists has experience treating all types of lung cancer, including lung cancer that has spread or returned. Your treatment plan will depend on several important factors, including: […] Well develop a coordinated and thorough treatment plan to fight your lung cancer, by using medication therapy, radiation therapy, cancer surgery or a combination of these treatment methods. […] Also referred to simply as chemo, chemotherapy uses a range of different drugs, usually inserted directly into the vein, to kill cancer cells, as well as to stop them from growing and dividing. […] Targeted therapy uses drugs that aim for specific areas inside cancer cells, leaving your healthy cells alone.
- #46https://www.mercy.net/service/lung-cancer/diagnosis-treatment/
While receiving a lung cancer diagnosis can be an extremely troubling event, there are treatment options available now that provide hope. […] Mercys team of cancer specialists has experience treating all types of lung cancer, including lung cancer that has spread or returned. Your treatment plan will depend on several important factors, including: […] Well develop a coordinated and thorough treatment plan to fight your lung cancer, by using medication therapy, radiation therapy, cancer surgery or a combination of these treatment methods. […] Also referred to simply as chemo, chemotherapy uses a range of different drugs, usually inserted directly into the vein, to kill cancer cells, as well as to stop them from growing and dividing. […] Targeted therapy uses drugs that aim for specific areas inside cancer cells, leaving your healthy cells alone.
- #47 Lung Cancer – Screening, Diagnosis & Treatment | IU Healthhttps://iuhealth.org/find-medical-services/lung-cancer
More advanced lung cancers are treated primarily with three categories of chemotherapy. […] Traditional chemotherapies are medications, often provided by infusions into your blood stream that attack fast-growing cells, a characteristic of cancers. […] More recently, we have recognized the growth of some lung cancers are driven by certain mutated growth factor receptors. […] The third category of chemotherapy is immunotherapy. This does not attack the cancer directly. Instead, this enhances the patientâs own immune system to more effectively attack the cancer cells. […] Clinical trials have led to significant advancements for several aspects in the treatment of lung cancer in recent years. […] Your physicians dedicate themselves to the prevention and early detection of lung cancer. […] At-risk patients can also receive lung cancer screenings to monitor your lung health. Early detection greatly improves your treatment options. […] A quick, non-invasive and painless lung screening can detect lung cancer at a very early stage and before symptoms appear.
- #48 Lung Cancer – Screening, Diagnosis & Treatment | IU Healthhttps://iuhealth.org/find-medical-services/lung-cancer
More advanced lung cancers are treated primarily with three categories of chemotherapy. […] Traditional chemotherapies are medications, often provided by infusions into your blood stream that attack fast-growing cells, a characteristic of cancers. […] More recently, we have recognized the growth of some lung cancers are driven by certain mutated growth factor receptors. […] The third category of chemotherapy is immunotherapy. This does not attack the cancer directly. Instead, this enhances the patientâs own immune system to more effectively attack the cancer cells. […] Clinical trials have led to significant advancements for several aspects in the treatment of lung cancer in recent years. […] Your physicians dedicate themselves to the prevention and early detection of lung cancer. […] At-risk patients can also receive lung cancer screenings to monitor your lung health. Early detection greatly improves your treatment options. […] A quick, non-invasive and painless lung screening can detect lung cancer at a very early stage and before symptoms appear.
- #49 Lung Cancer and Advances in Treatment, Surgery and Screening to Save Lives | Brown University Healthhttps://www.brownhealth.org/be-well/lung-cancer-and-advances-treatment-surgery-and-screening-save-lives
The use of minimally invasive approaches to lung cancer surgery, including video-assisted and robot-assisted surgery, has consistently been shown to improve short-term outcomes compared to open surgery. […] Many lung cancers grow and spread because they actively evade the immune system. Immune checkpoint inhibitors are antibodies which block the ability of the cancer cells to evade the immune system, thus fostering an immune attack. […] The goal of this approach is to foster immune attack so that a patients own immune system protects patients from metastatic spread, which can improve rates of cure. […] Lung cancer screening involves a low dose CT scan of the chest, which collects multiple images while the individual lies on a donut-shaped scanner table. […] Lung cancer screening with an annual low-dose CT improves survival by detecting these cancers at an early stage.
- #50 Lung cancer – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
Radiation therapy treats cancer with powerful energy beams. […] Chemotherapy treats cancer with strong medicines. […] Stereotactic body radiotherapy is an intense radiation treatment. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. […] Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system to kill cancer cells. […] Palliative care is a special type of healthcare that helps you feel better when you have a serious illness. […] The use of palliative care with other proper treatments can help people with cancer feel better and live longer.
- #51 Lung Cancer: Diagnosis, Treatment Principles, and Screening | AAFPhttps://www.aafp.org/pubs/afp/issues/2022/0500/p487.html
Lung cancer is the second most common cancer in men and women in the United States; however, it remains the leading cause of cancer-related death in the United States and worldwide. […] If lung cancer is confirmed, treatment options vary based on staging, histology, immunotherapy biomarker testing, and patient health status. Treatments include surgical resection, immunotherapy, chemotherapy, and/or radiotherapy. […] As of 2021, the U.S. Preventive Services Task Force recommends annual lung cancer screening using low-dose computed tomography starting at 50 years of age in patients with a 20 pack-year history. […] The treatment of NSCLC varies based on staging, nonsquamous (usually adenocarcinoma) vs. squamous histology, and genetic and immunotherapy biomarker testing. […] Patients with stages I to II NSCLC are usually offered a combination of three treatments: surgery, which can include complete resection of the tumor (usually stages I and II), and mediastinal lymph node dissection or lymph node sampling; radiotherapy; and adjuvant platinum-based chemotherapy.
- #52 Lung Cancer: Diagnosis, Treatment Principles, and Screening | AAFPhttps://www.aafp.org/pubs/afp/issues/2022/0500/p487.html
Lung cancer is the second most common cancer in men and women in the United States; however, it remains the leading cause of cancer-related death in the United States and worldwide. […] If lung cancer is confirmed, treatment options vary based on staging, histology, immunotherapy biomarker testing, and patient health status. Treatments include surgical resection, immunotherapy, chemotherapy, and/or radiotherapy. […] As of 2021, the U.S. Preventive Services Task Force recommends annual lung cancer screening using low-dose computed tomography starting at 50 years of age in patients with a 20 pack-year history. […] The treatment of NSCLC varies based on staging, nonsquamous (usually adenocarcinoma) vs. squamous histology, and genetic and immunotherapy biomarker testing. […] Patients with stages I to II NSCLC are usually offered a combination of three treatments: surgery, which can include complete resection of the tumor (usually stages I and II), and mediastinal lymph node dissection or lymph node sampling; radiotherapy; and adjuvant platinum-based chemotherapy.
- #53 Lung Cancer: Diagnosis, Treatment Principles, and Screening | AAFPhttps://www.aafp.org/pubs/afp/issues/2022/0500/p487.html
For patients with stage IV disease, palliative care and immunotherapy with or without platinum-based chemotherapy are recommended. […] For patients with limited-stage SCLC, the standard of care is etoposide (Etopophos) plus cisplatin chemotherapy and concurrent thoracic radiotherapy, with surgical resection offered in select patients. […] For patients with extensive-stage SCLC, four to six cycles of one of several combination chemotherapy/immunotherapy regimens should be offered with maintenance immunotherapy. […] Smoking cessation reduces morbidity and mortality in patients with lung cancer; however, no randomized controlled trials have compared specific cessation interventions in this population. […] Cessation assistance in combination with CT screening has been associated with a reduction in lung cancer-specific mortality and the potential to improve the cost-effectiveness ratio of screening.
- #54 Lung Cancer: Diagnosis, Treatment Principles, and Screening | AAFPhttps://www.aafp.org/pubs/afp/issues/2022/0500/p487.html
For patients with stage IV disease, palliative care and immunotherapy with or without platinum-based chemotherapy are recommended. […] For patients with limited-stage SCLC, the standard of care is etoposide (Etopophos) plus cisplatin chemotherapy and concurrent thoracic radiotherapy, with surgical resection offered in select patients. […] For patients with extensive-stage SCLC, four to six cycles of one of several combination chemotherapy/immunotherapy regimens should be offered with maintenance immunotherapy. […] Smoking cessation reduces morbidity and mortality in patients with lung cancer; however, no randomized controlled trials have compared specific cessation interventions in this population. […] Cessation assistance in combination with CT screening has been associated with a reduction in lung cancer-specific mortality and the potential to improve the cost-effectiveness ratio of screening.
- #55 Lung Cancer: Diagnosis, Treatment Principles, and Screening | AAFPhttps://www.aafp.org/pubs/afp/issues/2022/0500/p487.html
For patients with stage IV disease, palliative care and immunotherapy with or without platinum-based chemotherapy are recommended. […] For patients with limited-stage SCLC, the standard of care is etoposide (Etopophos) plus cisplatin chemotherapy and concurrent thoracic radiotherapy, with surgical resection offered in select patients. […] For patients with extensive-stage SCLC, four to six cycles of one of several combination chemotherapy/immunotherapy regimens should be offered with maintenance immunotherapy. […] Smoking cessation reduces morbidity and mortality in patients with lung cancer; however, no randomized controlled trials have compared specific cessation interventions in this population. […] Cessation assistance in combination with CT screening has been associated with a reduction in lung cancer-specific mortality and the potential to improve the cost-effectiveness ratio of screening.
- #56 Lung Cancer Early Detection | Lung Cancer Screening | American Cancer Societyhttps://www.cancer.org/cancer/types/lung-cancer/detection-diagnosis-staging/detection.html
The American Cancer Society recommends yearly screening for lung cancer with a low-dose CT (LDCT) scan for people ages 50 to 80 years who: Smoke or used to smoke AND Have at least a 20 pack-year history of smoking. […] The main benefit of screening is finding the cancer earlier and thus, lowering the chance of dying from lung cancer. […] LDCT scans can also find things that turn out not to be cancer, but that still have to be checked out with more tests to know what they are. […] To get the most benefit from screening, people need to be in fairly good health. For example, they need to be healthy enough to have surgery and receive other treatments if lung cancer is found. […] It’s important to talk to your doctor about all your health issues when deciding if lung cancer screening is right for you.
- #57 Lung Cancer Screening (PDQ®) – NCIhttps://www.cancer.gov/types/lung/hp/lung-screening-pdq
Two randomized trials have reported statistically significant reductions in lung cancer mortality associated with low-dose computed tomography (LDCT) screening. One trial reported that screening higher-risk individuals (30+ pack-years and either current smokers or quit within the past 15 years) aged 55 to 74 years three times, once annually, with LDCT reduced lung cancer mortality by 20% (95% confidence interval [CI], 6.8%26.7%; P = .004) and all-cause mortality by 6.7% (95% CI, 1.2%13.6%; P = .02) over screening with chest radiographs. […] The other trial reported that among high-risk current and former smokers, men who were randomly assigned to four rounds of LDCT screening had a 24% reduction (95% CI, 6%39%) in lung cancer mortality, compared with men who were randomly assigned to no screening.
- #58 What to Expect from a Lung Cancer Screening | Saved By The Scan | American Lung Associationhttps://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/screening-resources/what-to-expect-from-lung-cancer-screening
Lung cancer screenings are non-invasive and only take a few minutes. […] If you are worried about your lung cancer risk, you should consider talking to your doctor about lung cancer screening. Annual lung cancer screenings with low-dose CT scans (LDCT) has been shown to reduce deaths from lung cancer. It catches lung cancer earlier when it is more curable. […] The main benefit of lung cancer screening is preventing death from lung cancer. Lung cancer screening finds over half of lung cancer at an early stage when it is more curable, compared to only about 25% without screening. […] If you do have cancer, your doctor will likely recommend treatment which could include surgery, chemotherapy, radiation, immunotherapy or targeted therapies.
- #59 Lung Cancer Screening | Comprehensive Thoracic Oncology Program | Dartmouth Cancer Centerhttps://cancer.dartmouth.edu/lung-thoracic/lung-cancer-screening
It is essential to schedule an LDCT scan every year because new cancers can grow quickly, even after periods of slow growth. […] The benefits of diagnosing lung cancer early include: Lung cancer screening saves lives. Since lung cancer screening became available to people considered at high risk of lung cancer, more than 10,000 American lives have been saved. […] Treatment may be more successful. Research shows spotting lung cancer at the earliest stages improves the chances of survival. […] You may have more treatment choices. Patients with early-stage lung cancer often have choices of surgery, radiation, and chemotherapy. […] The risks of lung cancer screening include: False alarms. The scan might show something that looks like lung cancer but is not actually lung cancer. […] Overdiagnosis. Sometimes slow-growing cancer that might not otherwise have been diagnosed but also might not lead to illness or death is found. […] Like an X-ray, LDCT uses radiation, a type of energy that, if given in high doses or repeated exposure, can be harmful or cause cancer. […] Ask your healthcare provider to discuss your options or see if you qualify for a lung cancer screening that is covered by insurance.
- #60 caret_down iconhttps://www.spectrumhealth.org/services/cancer/symptoms-and-screenings/lung-cancer-screenings
Early detection is the most powerful tool against a lung cancer diagnosis. […] Lung cancer screening is a preventive health check, much like a mammogram or colonoscopy, to test for cancer before you have symptoms. It can save lives by finding cancer early, when it is easiest to treat. […] Lung cancer screening can help detect cancer early, when it is the most treatable, and increases the likelihood of a positive outcome. […] Screening for lung cancer has many key benefits: […] Early detection: Lung cancer often presents with minimal or no symptoms in its early stages, making it challenging to diagnose until it has progressed. Screening allows for identification of lung cancer at an earlier stage when treatment options are more effective. […] Improves survival rates: By detecting lung cancer at an early stage, treatment interventions can be implemented promptly, leading to better survival rates and improved long-term prognosis.
- #61 Screening for lung cancer – UpToDatehttps://www.uptodate.com/contents/screening-for-lung-cancer
Screening for lung cancer has been recommended broadly by many expert panels since 2014 for risk groups meeting specific smoking and demographic parameters. […] Despite broad recommendations from almost all expert panels, lung cancer screening has been poorly adopted. In fact, it is estimated that only approximately 15 percent of eligible candidates have been screened. […] Clinical outcome for non-small cell lung cancer is directly related to stage at the time of diagnosis. […] However, 75 percent of patients with lung cancer present with symptoms due to advanced local or metastatic disease that is not amenable to cure. […] Despite advances in therapy, five-year survival rates average approximately 18 percent for all individuals with lung cancer.
- #62 Patient education: Lung cancer prevention and screening (Beyond the Basics) – UpToDatehttps://www.uptodate.com/contents/lung-cancer-prevention-and-screening-beyond-the-basics
LUNG CANCER SCREENING TESTS […] Researchers have studied, and continue to study, different tests for lung cancer screening. […] Low-dose CT scan â A large, randomized trial (the National Lung Screening Trial [NLST]) in the United States compared the benefits of screening by low-dose computed tomography (CT) scan or standard chest X-ray in heavy smokers. Compared with chest X-ray, low-dose CT scan reduced the risk of death from lung cancer by 20 percent and the overall risk of death by about 7 percent. However, nearly a quarter of the people who had yearly low-dose CT screening for three years had an abnormal test, and more than 95 percent of the abnormal tests were „false positive,” meaning that they did not represent cancer. However, these people still required some sort of follow-up, usually just more imaging. Another large, randomized trial in Europe has also shown the benefit of chest CT scans for reducing lung cancer deaths among smokers and prior smokers.
- #63 Lung Cancer Screening – NCIhttps://www.cancer.gov/types/lung/patient/lung-screening-pdq
Screening is looking for cancer before a person has any symptoms. This can help find cancer at an early stage. When abnormal tissue or cancer is found early, it may be easier to treat. […] Screening with LDCT scans has been shown to decrease the risk of dying from lung cancer in heavy smokers. […] Screening with chest x-rays and/or sputum cytology does not decrease the risk of dying from lung cancer. […] Screening tests have risks. […] Finding lung cancer may not improve health or help you live longer. […] False-negative test results can occur. […] False-positive test results can occur. […] Chest x-rays and CT scans expose the chest to radiation. […] Talk to your doctor about your risk for lung cancer and your need for screening tests.
- #64 Lung Cancer Screening | Comprehensive Thoracic Oncology Program | Dartmouth Cancer Centerhttps://cancer.dartmouth.edu/lung-thoracic/lung-cancer-screening
It is essential to schedule an LDCT scan every year because new cancers can grow quickly, even after periods of slow growth. […] The benefits of diagnosing lung cancer early include: Lung cancer screening saves lives. Since lung cancer screening became available to people considered at high risk of lung cancer, more than 10,000 American lives have been saved. […] Treatment may be more successful. Research shows spotting lung cancer at the earliest stages improves the chances of survival. […] You may have more treatment choices. Patients with early-stage lung cancer often have choices of surgery, radiation, and chemotherapy. […] The risks of lung cancer screening include: False alarms. The scan might show something that looks like lung cancer but is not actually lung cancer. […] Overdiagnosis. Sometimes slow-growing cancer that might not otherwise have been diagnosed but also might not lead to illness or death is found. […] Like an X-ray, LDCT uses radiation, a type of energy that, if given in high doses or repeated exposure, can be harmful or cause cancer. […] Ask your healthcare provider to discuss your options or see if you qualify for a lung cancer screening that is covered by insurance.
- #65 Lung Cancer Screening – NCIhttps://www.cancer.gov/types/lung/patient/lung-screening-pdq
Screening is looking for cancer before a person has any symptoms. This can help find cancer at an early stage. When abnormal tissue or cancer is found early, it may be easier to treat. […] Screening with LDCT scans has been shown to decrease the risk of dying from lung cancer in heavy smokers. […] Screening with chest x-rays and/or sputum cytology does not decrease the risk of dying from lung cancer. […] Screening tests have risks. […] Finding lung cancer may not improve health or help you live longer. […] False-negative test results can occur. […] False-positive test results can occur. […] Chest x-rays and CT scans expose the chest to radiation. […] Talk to your doctor about your risk for lung cancer and your need for screening tests.
- #66 CT Lung Cancer Screening: Uses, Risks, Procedure, Resultshttps://www.verywellhealth.com/ct-lung-cancer-screening-2249404
The U.S. Preventive Services Task Force (USPSTF) recommends annual lung screening for those who are: Between the ages of 50 and 80, Who have at least a 20 pack-year history of smoking, Who currently smoke or have quit in the past 15 years. […] Individuals must meet all of the above-listed criteria for the test to be considered appropriate. […] The American Cancer Society also recommends screening for current or former smokers ages 50 to 80 who have at least a 20 pack-year history. […] As with all radiotherapy procedures, the benefits and risks should be weighed prior to the test. […] LDCT screening exposes you to ionizing radiation, albeit at lower doses than those used for traditional CT scans. […] Although studies have shown CT lung screening is 20% more accurate in diagnosing lung cancer than a chest X-ray, the annual exposure to radiation does pose potential health concerns.
- #67 Lung Cancer Screening | Clearview Cancer Institutehttps://www.clearviewcancer.com/cancer-treatment/lung-cancer-screening/
The lung screening CT scan uses a lower dose of radiation than the standard CT scan. This level of exposure is similar to a mammogram, which is the standard screening method for breast cancer detection. […] While the radiation exposure of a low dose CT scan is minimal, it is still considered a risk. The amount of radiation for the lung screening is similar to the amount given for a mammogram which is considered the gold standard for breast cancer detection. Scans may also reveal nodules that are not cancerous, so the anxiety associated with false positives needs to be taken into consideration when making your decision. […] The American Cancer Society recommends yearly screening for high risk patients until they reach 80 years of age.
- #68 Lung cancer screening – Mayo Clinichttps://www.mayoclinic.org/tests-procedures/lung-cancer-screening/about/pac-20385024
Not all medical groups agree on the age at which you may consider stopping lung cancer screening. In general, continue annual lung cancer screening until you reach a point at which you’re unlikely to benefit from screening, such as when you develop other serious health conditions that may make you too frail to undergo lung cancer treatment. […] Lung cancer screening carries several risks, such as: […] Finding cancer that’s too advanced to cure. Advanced lung cancers, such as those that have spread, may not respond well to treatment, so finding these cancers on a lung cancer screening test might not improve or extend your life. […] If you’re diagnosed with lung cancer, your doctor will likely recommend treatment. Treatment for cancers that would have remained small and confined the rest of your life may not help you and may be unnecessary.
- #69 Lung Cancer Screening – NCIhttps://www.cancer.gov/types/lung/patient/lung-screening-pdq
Screening is looking for cancer before a person has any symptoms. This can help find cancer at an early stage. When abnormal tissue or cancer is found early, it may be easier to treat. […] Screening with LDCT scans has been shown to decrease the risk of dying from lung cancer in heavy smokers. […] Screening with chest x-rays and/or sputum cytology does not decrease the risk of dying from lung cancer. […] Screening tests have risks. […] Finding lung cancer may not improve health or help you live longer. […] False-negative test results can occur. […] False-positive test results can occur. […] Chest x-rays and CT scans expose the chest to radiation. […] Talk to your doctor about your risk for lung cancer and your need for screening tests.
- #70 Lung Cancer Screening and Guidelineshttps://www.cancercenter.com/cancer-types/lung-cancer/diagnosis-and-detection/screening-guidelines
To mitigate these risks as much as possible, screening is only recommended for high-risk patients. Patients should talk to their doctor to learn more about the benefits and risks of lung cancer screening. […] Your multidisciplinary team will work with you to develop a personalized plan to treat your lung cancer in a way that fits your individual needs and goals.
- #71 Lung Cancer Screeninghttps://pmc.ncbi.nlm.nih.gov/articles/PMC6467530/
The goal of screening is to detect disease at a stage when it is not causing symptoms and when treatment is most successful. Screening should benefit the individual by increasing life expectancy and increasing quality of life. The rate of false-positive results should be low to prevent unnecessary additional testing. The large fraction of the population without the disease should not be harmed (low risk), and the screening test should not be so expensive that it places an onerous burden on the health care system. Thus, the screening test should: 1) improve outcome; 2) be scientifically validated (e.g., have acceptable levels of sensitivity and specificity); and 3) be low risk, reproducible, accessible, and cost effective. […] Lung cancer screening with CT should be part of a program of care and should not be performed in isolation as a free-standing test. Given the high percentage of false-positive results and the downstream management that ensues for many patients, the risks and benefits of lung cancer screening should be discussed with the individual before a screening LDCT scan is performed. It is recommended that institutions performing lung cancer screening use a multidisciplinary approach that may include specialties such as radiology, pulmonary medicine, internal medicine, thoracic oncology, and thoracic surgery. Management of downstream testing and follow-up of small nodules are imperative and may require the establishment of administrative processes to ensure adequate follow-up.
- #72 UNC Early Detection of Lung Cancer Program – UNC Linebergerhttps://unclineberger.org/lung-cancer-screening-clinic/
UNC Hospitals and the UNC Lineberger Comprehensive Cancer Center offer a state-of-the-art lung cancer screening clinic. Eligible patients can have a consultation and scan on the same day, and typically receive results within 24 hours. […] Annual low-dose CT (LDCT) lung cancer screening is now covered by insurance, including Medicare and most private insurers, for eligible patients. […] A large study found that screening for lung cancer with LDCT helped to catch some cancers early enough to save lives. However, like all screening tests, there are some trade-offs, and patients must decide for themselves whether or not the benefits outweigh the risks. […] Patients referred to the clinic speak with Dr. Long and the clinics Nurse Navigator, Michelle Ottersbach, one-on-one as they review the possible risks and benefits of being screened. The patients personal risk factors are taken into account as Dr. Long and the patient work together to reach a decision.
- #73 Early Detection of Lung Cancer – Early Lung Cancer Screening Programhttps://www.hoag.org/specialties-services/cancer/conditions/lung-cancer/screening/
The treatment success for metastatic lung cancer can be limited. However, patients with stage 1 lung cancers, or early small lung cancers, detected before spreading, have much better survival rates. […] A smoker who stops smoking will significantly reduce his/her risk of lung cancer. However, the risk of cancer will not decrease to the low risk of someone who has never smoked. […] During the imaging test, you will need to lie down on the CT table and hold your breath for about 10 15 seconds, while the images are taken. Your results will be provided to your referring physician, who will review them with you during a follow-up consultation.
- #74 UNC Early Detection of Lung Cancer Program – UNC Linebergerhttps://unclineberger.org/lung-cancer-screening-clinic/
Patients choosing to be screened can have the exam performed at the UNC Imaging Spine Center. The LDCT scan is read in real time by a dedicated chest radiologist and results are reported directly to Dr. Long. […] If results require additional follow-up, Dr. Long is there with the patient every step of the way, answering questions, explaining results, and providing support. […] Additionally, smoking cessation counseling is available during the clinic visit. Patients who are currently smoking and interested in quitting will meet with the Smoking Cessation Counselor to determine treatment options for cessation.
- #75 Lung Cancer Screening Tool – Color Healthhttps://www.color.com/lung-cancer-screening-tool
The American Cancer Society recommends yearly lung cancer screening with a low-dose CT scan (LDCT) for those who meet all of the criteria below: […] Early detection can save your life. People whose lung cancer is detected early have seven times better 5-year-survival rates. […] A low-dose CT scan of your lungs is the recommended screening test. […] Getting this screening test regularly can catch lung cancer early even before symptoms show up. […] Catching cancer early often allows for a higher likelihood of successful treatment. […] That means a person who used to smoke with at least a 20 pack-year history, whether they quit yesterday or 30 years ago, is considered to have a high risk for developing lung cancer and should be screened with a yearly low-dose CT scan. […] If your CT scan finds something abnormal, like a lung nodule, your clinician may recommend repeating the CT scan at a later date to see if it changes over time. Depending on the size, shape and location, your clinician might recommend seeing a pulmonologist for further evaluation, which may include taking a small sample (biopsy) of the nodule to check for cancer cells.
- #76 Lung Cancer Screening Programhttps://www.karmanos.org/karmanos/lung-cancer-screening-program-at-karmanos
Karmanos follows USPSTF guidelines for Lung Cancer Screening. […] Lung cancer screening is covered by Medicare for patients 50-77 years old and most commercial insurance plans cover it for patients 55-80 years old. Typically, there is no out-of-pocket cost for low-dose CT lung screening, but confirm with your health insurance provider. […] Screening for lung cancer is a process, and cannot be completed with a single test. The data available show that individuals who do qualify for lung cancer screening should have a yearly screening CT scan. […] The screening process includes a visit with a Karmanos provider, a lung cancer specialist, to discuss risks and benefits of lung cancer screening. […] Those who are eligible for the program have annual low-dose CT scans. […] A Karmanos radiologist will review the patients CT scans for abnormalities and track any yearly changes. We will send the patients primary health care provider copies of the results.
- #77 Lung Cancer Screening Programhttps://www.karmanos.org/karmanos/lung-cancer-screening-program-at-karmanos
The radiologist may recommend follow up with either a Karmanos specialist or primary health care provider for further tests. […] The experts on this team focus primarily on the diagnosis and treatment of lung cancer and therefore have a level of expertise that other centers may not have. In addition, lung cancer screening may indicate further follow up that requires this level of expertise. […] Early detection of lung cancer increases the chance for successful treatment. Screening for cancer is done with low-dose spiral computed tomography (CT scan). […] The lung cancer specialists at Karmanos recommend screening for: Individuals between the ages of 55 and 80, Current or former smokers with at least a 20 pack-year smoking history, Individuals who have smoked one pack a day for 20 years or 2 packs a day for 10 years, Former smokers who have quit smoking in the last 15 years.
- #78 Lung Cancer Screeninghttps://pmc.ncbi.nlm.nih.gov/articles/PMC6467530/
The goal of screening is to detect disease at a stage when it is not causing symptoms and when treatment is most successful. Screening should benefit the individual by increasing life expectancy and increasing quality of life. The rate of false-positive results should be low to prevent unnecessary additional testing. The large fraction of the population without the disease should not be harmed (low risk), and the screening test should not be so expensive that it places an onerous burden on the health care system. Thus, the screening test should: 1) improve outcome; 2) be scientifically validated (e.g., have acceptable levels of sensitivity and specificity); and 3) be low risk, reproducible, accessible, and cost effective. […] Lung cancer screening with CT should be part of a program of care and should not be performed in isolation as a free-standing test. Given the high percentage of false-positive results and the downstream management that ensues for many patients, the risks and benefits of lung cancer screening should be discussed with the individual before a screening LDCT scan is performed. It is recommended that institutions performing lung cancer screening use a multidisciplinary approach that may include specialties such as radiology, pulmonary medicine, internal medicine, thoracic oncology, and thoracic surgery. Management of downstream testing and follow-up of small nodules are imperative and may require the establishment of administrative processes to ensure adequate follow-up.
- #79 What is Lung Cancer Screening? | Roswell Park Comprehensive Cancer Center – Buffalo, NYhttps://www.roswellpark.org/cancer/lung/prevention-screening/lung-cancer-screening-program
Our Lung Cancer Screening Program is designed to detect lung cancer early when it is most curable by screening and monitoring the people most likely to develop the disease, especially smokers. The program involves: […] Our screening focuses on people at high risk for developing lung cancer and as a result, 70% of the cancers we find with screening are early stage (stage 0, 1 and 2) compared to national statistics that show 70% of lung cancers are diagnosed at advanced stages (stage 3 or 4). […] If lesions or nodules are found, you may undergo further tests and biopsy to determine whether it’s actually cancer, or have repeat CT scans at recommended intervals. These decisions are based on the size, character and number of nodules found. […] If you need a biopsy, Roswell Park uses the latest minimally invasive approaches including endobronchial ultrasound and robotic bronchoscopy, to safely perform the biopsy and get the answers you need to determine your next steps. […] An advanced technology Robotic Bronchoscopy is a game-changer for getting accurate biopsies of very small nodules deep in the lungs without surgery.
- #80https://www.mercy.net/service/lung-cancer/diagnosis-treatment/
While receiving a lung cancer diagnosis can be an extremely troubling event, there are treatment options available now that provide hope. […] Mercys team of cancer specialists has experience treating all types of lung cancer, including lung cancer that has spread or returned. Your treatment plan will depend on several important factors, including: […] Well develop a coordinated and thorough treatment plan to fight your lung cancer, by using medication therapy, radiation therapy, cancer surgery or a combination of these treatment methods. […] Also referred to simply as chemo, chemotherapy uses a range of different drugs, usually inserted directly into the vein, to kill cancer cells, as well as to stop them from growing and dividing. […] Targeted therapy uses drugs that aim for specific areas inside cancer cells, leaving your healthy cells alone.
- #81 Lung Cancer Treatment | UCLA Health Jonsson Comprehensive Cancer Centerhttps://www.uclahealth.org/cancer/cancer-services/lung-cancer
We focus on finding lung cancer at its earliest stages. […] Our experience and expertise help us identify cancer quickly and accurately. […] UCLA Health specialists use precision medicine to tailor your treatment plan. […] At UCLA Health, we meet weekly as the Thoracic Oncology Program (TOP) tumor board a group of expert oncology physicians from different specialties. […] Youâll have oncology nurse navigators and specialized nurse practitioners by your side every step of the way. […] Our researchers help develop new and advanced lung cancer treatments. […] At UCLA Health, lung cancer specialists have experience with advanced treatments and therapies. […] Medical oncology uses drugs and other agents to find and destroy cancer cells. […] Medical oncology treatments for lung cancer include:
- #82 Lung Cancer Screening Program | Inovahttps://www.inova.org/our-services/lung-cancer-screening-program
Annual lung cancer screening with low-dose computed tomography (LDCT) is recommended for adults ages 50 to 80 who have a 20 pack-year smoking history and currently smoke, or have quit within the past 15 years. […] Inova Lung Cancer Screening program is designed to detect cancer in its earliest, most treatable stage. […] Should cancer be detected, a multidisciplinary team of board certified interventional pulmonologists, thoracic surgeons and thoracic medical and radiation oncologists work hand-in-hand to coordinate and manage your care. […] We offer comprehensive, minimally invasive diagnostic and treatment options for lung cancer patients. […] Nearly all lung cancers are carcinomas, a cancer that begins in the lining or covering tissues of an organ. The tumor cells of each type of lung cancer grow and spread differently, and each type requires different treatment. […] View lung cancer treatment options available.
- #83 Lung Cancer Screening | Eligibility & Types | MedStar Healthhttps://www.medstarhealth.org/services/lung-cancer-screening
That’s why it’s important to seek follow-up testing to accurately diagnose and monitor lung nodules. […] A lung nodule is a mass of tissue that has formed in a place where it should not be. Many times lung nodules are harmless, but in some cases, lung nodules can turn out to be cancer. […] Your team will tailor a management plan unique to you based on the best studies available.
- #84 Screening for lung cancer – UpToDatehttps://www.uptodate.com/contents/screening-for-lung-cancer
Screening for lung cancer has been recommended broadly by many expert panels since 2014 for risk groups meeting specific smoking and demographic parameters. […] Despite broad recommendations from almost all expert panels, lung cancer screening has been poorly adopted. In fact, it is estimated that only approximately 15 percent of eligible candidates have been screened. […] Clinical outcome for non-small cell lung cancer is directly related to stage at the time of diagnosis. […] However, 75 percent of patients with lung cancer present with symptoms due to advanced local or metastatic disease that is not amenable to cure. […] Despite advances in therapy, five-year survival rates average approximately 18 percent for all individuals with lung cancer.
- #85 UNC Early Detection of Lung Cancer Program – UNC Linebergerhttps://unclineberger.org/lung-cancer-screening-clinic/
Patients choosing to be screened can have the exam performed at the UNC Imaging Spine Center. The LDCT scan is read in real time by a dedicated chest radiologist and results are reported directly to Dr. Long. […] If results require additional follow-up, Dr. Long is there with the patient every step of the way, answering questions, explaining results, and providing support. […] Additionally, smoking cessation counseling is available during the clinic visit. Patients who are currently smoking and interested in quitting will meet with the Smoking Cessation Counselor to determine treatment options for cessation.
- #86 The Lung Cancer Policy Networkhttps://www.lungcancerpolicynetwork.com/
The interactive map of lung cancer screening is a comprehensive resource that showcases low-dose computed tomography (LDCT) screening programmes around the world. […] This report presents practical and evidence-based tools to support the development and implementation of an early detection strategy for lung cancer. […] The Lung Cancer Policy Network has developed an implementation framework to support those involved in the planning of lung cancer screening programmes around the world. […] We aim to do this by engaging with policymakers to make lung cancer a policy priority, encouraging the adoption of LDCT screening for lung cancer, continuing to advocate for the early detection of lung cancer, and optimising the way people access lung cancer diagnoses and treatment. […] The report, Patient navigation for lung cancer: an essential component of care, explores how health system leaders and decision-makers should develop formal patient navigation programmes where they do not exist.
- #87
- #88 Lung Cancer Screening – UChicago Medicinehttps://www.uchicagomedicine.org/cancer/types-treatments/lung-cancer/screening
Lung cancer screening can help. With screening, lung cancer can be diagnosed at an early stage when it’s more curable. […] Lung cancer screening involves a low dose computed tomography, or LDCT scan of a patient’s chest to make detailed pictures of the lungs. […] If your screening shows you may have cancer, our multidisciplinary lung cancer team works together to determine which treatments will be most effective for you. […] Lung cancer screening is a method of monitoring patients who are in reasonably good health but have an increased risk of developing lung cancer. […] Through screening, physicians can identify potential early-stage cancer and begin treatment sooner to reduce the number of patients who progress to end-stage cancer or die from the disease. […] Studies have shown that lung cancer screening can reduce the risk of death from lung cancer by 20 percent.
- #89 Lung Cancer: Diagnosis, Treatment Principles, and Screening | AAFPhttps://www.aafp.org/pubs/afp/issues/2022/0500/p487.html
For patients with stage IV disease, palliative care and immunotherapy with or without platinum-based chemotherapy are recommended. […] For patients with limited-stage SCLC, the standard of care is etoposide (Etopophos) plus cisplatin chemotherapy and concurrent thoracic radiotherapy, with surgical resection offered in select patients. […] For patients with extensive-stage SCLC, four to six cycles of one of several combination chemotherapy/immunotherapy regimens should be offered with maintenance immunotherapy. […] Smoking cessation reduces morbidity and mortality in patients with lung cancer; however, no randomized controlled trials have compared specific cessation interventions in this population. […] Cessation assistance in combination with CT screening has been associated with a reduction in lung cancer-specific mortality and the potential to improve the cost-effectiveness ratio of screening.
- #90 Lung Cancer: Diagnosis, Treatment Principles, and Screening | AAFPhttps://www.aafp.org/pubs/afp/issues/2022/0500/p487.html
For patients with stage IV disease, palliative care and immunotherapy with or without platinum-based chemotherapy are recommended. […] For patients with limited-stage SCLC, the standard of care is etoposide (Etopophos) plus cisplatin chemotherapy and concurrent thoracic radiotherapy, with surgical resection offered in select patients. […] For patients with extensive-stage SCLC, four to six cycles of one of several combination chemotherapy/immunotherapy regimens should be offered with maintenance immunotherapy. […] Smoking cessation reduces morbidity and mortality in patients with lung cancer; however, no randomized controlled trials have compared specific cessation interventions in this population. […] Cessation assistance in combination with CT screening has been associated with a reduction in lung cancer-specific mortality and the potential to improve the cost-effectiveness ratio of screening.
- #91 Lung Cancerhttps://www.siemens-healthineers.com/clinical-specialities/oncology/cancer-types/lung-cancer
Our comprehensive tumor marker test menu can be used for auxiliary and differential diagnosis as well as to predict the possible pathological types of lung cancer. In addition, our tumor marker tests can aid in the assessment of response to therapy, residual disease following treatment and disease recurrence. […] Therapy monitoring and follow-up in lung cancer are key to personalizing patient care. Monitoring tumor response allows for timely adjustment of the chosen therapy.
- #92 Lung cancer: New screening test with an inhaler may help diagnosehttps://www.medicalnewstoday.com/articles/researchers-developing-an-inhalable-screening-test-for-lung-cancer
Researchers say they have developed a new way to detect lung cancer at its earliest stages using an inhaler and a simple urine test. […] Many lung cancers can be cured if detected early, particularly with surgical resection, Spallone told Medical News Today. However, surgery is an available option only before the cancer has spread or become too invasive to resect. […] This new lung cancer screening test was tested on a mouse model during this study. […] The research team reportedly plans to next test the sensors on human biopsy samples and eventually perform clinical trials on humans. […] Another exciting application of the PATROL platform is therapeutic monitoring. For instance, it could serve as a tool to assess patients responses to specific treatments. […] The other aspect that I love is the ease of the proposed test, Spallone added. Many patients are familiar with using an inhaler and a urine test is one of simplest diagnostic tools available for patients. It doesnt involve needles or radiation such as an X-ray or CT scan. […] I have a lot of optimism that it could become a more attractive and available option to those appropriate for lung cancer screening in (the) future.
- #93 Lung Cancer Screening Guidelines | American Cancer Societyhttps://www.cancer.org/health-care-professionals/american-cancer-society-prevention-early-detection-guidelines/lung-cancer-screening-guidelines.html
ACS researcher, Bob Smith, PhD, and others propose that expanding screening to people who formerly smoked, with more than 15 years since quitting (YSQ), would reduce deaths from lung cancer and increase life years, and that additional harms could be moderated by restricting recommendations to only those with reasonable life expectancy. […] Authors evaluate cancer risks due to ionizing radiation and find benefit-to-radiation-risk ratios are highly favorable for current low-dose computed tomography lung cancer screening. Their results emphasize the importance of using modern CT technologies, maintaining low follow-up rates, and minimizing both screening and follow-up radiation doses. […] Multiple lines of reasoning and evidence have converged to indicate that using the 15 years or less quit-years rule to determine lung cancer screening eligibility should be abandoned.
- #94 Lung cancer: New screening test with an inhaler may help diagnosehttps://www.medicalnewstoday.com/articles/researchers-developing-an-inhalable-screening-test-for-lung-cancer
Researchers say they have developed a new way to detect lung cancer at its earliest stages using an inhaler and a simple urine test. […] Many lung cancers can be cured if detected early, particularly with surgical resection, Spallone told Medical News Today. However, surgery is an available option only before the cancer has spread or become too invasive to resect. […] This new lung cancer screening test was tested on a mouse model during this study. […] The research team reportedly plans to next test the sensors on human biopsy samples and eventually perform clinical trials on humans. […] Another exciting application of the PATROL platform is therapeutic monitoring. For instance, it could serve as a tool to assess patients responses to specific treatments. […] The other aspect that I love is the ease of the proposed test, Spallone added. Many patients are familiar with using an inhaler and a urine test is one of simplest diagnostic tools available for patients. It doesnt involve needles or radiation such as an X-ray or CT scan. […] I have a lot of optimism that it could become a more attractive and available option to those appropriate for lung cancer screening in (the) future.
- #95 Lung Cancer | AstraZenecahttps://www.astrazeneca.com/our-therapy-areas/oncology/at-the-forefront-of-lung-cancer-treatment.html
We are defining new biomarkers and therapeutic targets to transform the way lung cancer is diagnosed and treated. Our research has led us to address the unmet needs of patients with mutations in the epidermal growth factor receptor (EGFR). […] We are investigating antibody drug conjugates (ADCs) to target actionable biomarkers such as human epidermal growth factor 2 (HER2). […] Immunotherapies are designed to target immune checkpoints that are exploited by cancer to avoid or suppress the immune systems ability to recognise and destroy cancer cells. […] While many new treatments have focused on advancing care for metastatic patients with a high unmet medical need, we prioritised pushing treatment into earlier lung cancer settings. To really cure cancer, we need to treat earlier to maximise the potential for long-term disease remission and the possibility of cure.
- #96 Lung Cancer | AstraZenecahttps://www.astrazeneca.com/our-therapy-areas/oncology/at-the-forefront-of-lung-cancer-treatment.html
We are defining new biomarkers and therapeutic targets to transform the way lung cancer is diagnosed and treated. Our research has led us to address the unmet needs of patients with mutations in the epidermal growth factor receptor (EGFR). […] We are investigating antibody drug conjugates (ADCs) to target actionable biomarkers such as human epidermal growth factor 2 (HER2). […] Immunotherapies are designed to target immune checkpoints that are exploited by cancer to avoid or suppress the immune systems ability to recognise and destroy cancer cells. […] While many new treatments have focused on advancing care for metastatic patients with a high unmet medical need, we prioritised pushing treatment into earlier lung cancer settings. To really cure cancer, we need to treat earlier to maximise the potential for long-term disease remission and the possibility of cure.
- #97 Lung cancer screening A lever to reduce cancer mortalityhttps://www.siemens-healthineers.com/clinical-specialities/oncology/cancer-types/lung-cancer/lung-cancer-screening
Lung cancer is the #1 in cancer mortality, with 80% 5-year-mortality. As the early stages of the disease are painless, the majority of diagnoses happen in late stages. Today, around 80% of the patients are diagnosed in stage 3/4, where only palliative treatment is possible. […] Personalized screening of high risk groups with low-dose-CT is a way to significantly decrease lung cancer mortality. In current lung screening programs, around 80% of the patients are diagnosed in stage I or II, which allows treating them with curative intent. […] Depending on the stage and cancer type, the treatment could be e.g. surgery, chemo, radiation, immunotherapy. Because lung cancer is asymptomatic up to a certain stage, it is detected too late in many cases. With the introduction of lung cancer screening, it is expected that more cases are discovered in an earlier stage. Therefore, the current therapy mix of surgery, radiation therapy and chemotherapy will probably change to less invasive and more gentle methods. Key-hole surgery, stereotactic radiation therapy and local ablation techniques and combinations may become more important. Intra-procedural imaging plays a paramount role to conduct such interventions safely and efficiently. […] To increase overall survival, it is crucial that modern treatment options are available and accessible.
- #98 Lung Cancer: Breakthroughs in Detection and Treatmenthttps://www.webmd.com/lung-cancer/lung-cancer-treatment-advances
Lung cancer treatment is changing, thanks to breakthroughs and early detection. There are surgical advances, improvements in radiation, and new drugs that target specific traits of the cancer and stimulate your immune system to fight the disease. […] Research shows that people who got LDCT had their risk of dying from the disease drop by 20% against those who got chest X-rays. […] Doctors can treat some small lung tumors using this operation. […] Machines with built-in imaging scanners make it possible for your doctor to give radiation more precisely. […] Also known as immunotherapy, this can get your immune system to recognize and destroy cancer cells better. […] Scientists have learned that people with specific genetic combinations may benefit from targeted therapies like EGFR (epidermal growth factor receptor) blockers. […] Although a lot of studies are focused on the pursuit of new ways to treat lung cancer, researchers are always looking for new chemotherapy drugs or improvements on existing ones.
- #99 Lung Cancer | AstraZenecahttps://www.astrazeneca.com/our-therapy-areas/oncology/at-the-forefront-of-lung-cancer-treatment.html
We are defining new biomarkers and therapeutic targets to transform the way lung cancer is diagnosed and treated. Our research has led us to address the unmet needs of patients with mutations in the epidermal growth factor receptor (EGFR). […] We are investigating antibody drug conjugates (ADCs) to target actionable biomarkers such as human epidermal growth factor 2 (HER2). […] Immunotherapies are designed to target immune checkpoints that are exploited by cancer to avoid or suppress the immune systems ability to recognise and destroy cancer cells. […] While many new treatments have focused on advancing care for metastatic patients with a high unmet medical need, we prioritised pushing treatment into earlier lung cancer settings. To really cure cancer, we need to treat earlier to maximise the potential for long-term disease remission and the possibility of cure.
- #100 Lung Cancer Screening | Comprehensive Thoracic Oncology Program | Dartmouth Cancer Centerhttps://cancer.dartmouth.edu/lung-thoracic/lung-cancer-screening
It is essential to schedule an LDCT scan every year because new cancers can grow quickly, even after periods of slow growth. […] The benefits of diagnosing lung cancer early include: Lung cancer screening saves lives. Since lung cancer screening became available to people considered at high risk of lung cancer, more than 10,000 American lives have been saved. […] Treatment may be more successful. Research shows spotting lung cancer at the earliest stages improves the chances of survival. […] You may have more treatment choices. Patients with early-stage lung cancer often have choices of surgery, radiation, and chemotherapy. […] The risks of lung cancer screening include: False alarms. The scan might show something that looks like lung cancer but is not actually lung cancer. […] Overdiagnosis. Sometimes slow-growing cancer that might not otherwise have been diagnosed but also might not lead to illness or death is found. […] Like an X-ray, LDCT uses radiation, a type of energy that, if given in high doses or repeated exposure, can be harmful or cause cancer. […] Ask your healthcare provider to discuss your options or see if you qualify for a lung cancer screening that is covered by insurance.
- #101
- #102 Patient education: Lung cancer prevention and screening (Beyond the Basics) – UpToDatehttps://www.uptodate.com/contents/lung-cancer-prevention-and-screening-beyond-the-basics
PREVENTING LUNG CANCER […] Cigarette smoking is responsible for almost 90 percent of cases of lung cancer; secondhand smoke exposure also increases risk. Environmental exposure to radon (a colorless and odorless gas) is an important and modifiable risk factor for lung cancer among both smokers and non-smokers. In addition, exposure to certain other substances, such as asbestos, has been linked to the development of lung cancer. […] The best way to prevent lung cancer is to avoid smoking; don’t start smoking, or if you already smoke, quit. Some people believe that once they have smoked for a long time, there is little point in quitting. However, studies have shown that smokers who quit decrease their risk of lung cancer when compared with those who continue to smoke. Smokers who quit for more than 15 years have an 80 to 90 percent reduction in their risk of lung cancer compared with people who continue to smoke. Quitting smoking can be challenging, but help is available, and your health care provider can support you. (See „Patient education: Quitting smoking (Beyond the Basics).”)
- #103 Lung Cancer | AstraZenecahttps://www.astrazeneca.com/our-therapy-areas/oncology/at-the-forefront-of-lung-cancer-treatment.html
To meet this goal, the Alliance advocates for improved approaches in three key areas: Increasing screening rates and diagnostic testing; Accelerating the delivery of innovative medicine; Improving quality of care. […] Recent and ongoing initiatives include policy reports, like Lung Cancer Screening: The Cost of Inaction which outlines the opportunity presented by lung cancer screening to reduce costs while saving lives.
- #104 Identifying Best Practices and Gaps in Early-Stage Lung Cancer: From Screening and Early Detection Through Resectable Disease Treatment – Journal of Oncology Navigation & Survivorshiphttps://www.jons-online.com/issues/2022/february-2022-vol-13-no-2/4384-identifying-best-practices-and-gaps-in-early-stage-lung-cancer-from-screening-and-early-detection-through-resectable-disease-treatment
Lung cancer, which includes both nonsmall-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), is the second most commonly diagnosed cancer in both men and women. Notably, early-stage lung cancer has a better prognosis and is often more responsive to treatment than those identified at a more advanced stage. The goal of lung cancer screening and incidental pulmonary nodule management programs is to detect lung cancer early in an effort to facilitate treatment that is likely to be curative. Screening recommendations have been published to contribute to earlier detection, improve patient outcomes, and decrease the burden of lung cancer. Data from randomized trials have demonstrated a significant association between reduced lung cancer mortality and low-dose computed tomography (CT) screening. According to the National Lung Screening Trial eligibility criteria, low-dose CT screening should be completed annually for 3 years on patients aged 55 to 74 years who are at higher risk, including those with a 30-plus pack-year cigarette smoking history and current smoking status, or those who quit in the past 15 years. Such screening has led to a 20% reduction in risk in lung cancer mortality and a 6.7% reduction in all-cause mortality compared with the use of chest radiographs. The USPSTF recommends annual lung cancer screening with low-dose CT in adults aged 50 to 80 years who have a 20 pack-year history of cigarette smoking and currently smoke, or who have quit within the past 15 years. Screening should be discontinued when a patient has not smoked for 15 years, have developed a comorbid condition that substantially limits life expectancy, or if the patient does not have the clinical ability or personal willingness to undergo curative treatment. Current best practices in lung cancer screening recommendations include the USPSTF Lung Cancer Screening recommendations and the Lung Imaging Reporting and Data System (Lung-RADS). Navigators involved in lung cancer screening programs should be aware of the USPSTF lung cancer screening recommendations and the Lung-RADS classification system. Understanding and identifying the appropriate patient population along with following the aforementioned guidelines for managing nodules allow for more streamlined care coordination. The targeted population for lung cancer screening includes a high prevalence of current everyday smokers. Using data from the National Lung Screening Trial, current smokers who underwent screening that was suspicious for, but not diagnostic of, lung cancer were significantly more likely to stop smoking within 1 year. The inclusion of a pulmonary nodule in a radiology report is helpful, but evidence demonstrates that 40% of patients with incidental nodule findings receive follow-up. Gaps regarding biomarker testing for patients with lung cancer pertain to insurance coverage, tissue acquisition and tissue adequacy, and provider and patient/caregiver education. Obtaining biomarker analysis on patients with adenocarcinoma histology may aid in defining further treatment decisions.